Fast neutron relative biological effectiveness determination via proton bombardment of V79 cells by Sitek, Mark Andrew, 1974-
Fast Neutron Relative Biological Effectiveness Determination via Proton
Bombardment of V79 Cells
by
Mark Andrew Sitek
B.S. Nuclear Engineering (1996)
Rensselaer Polytechnic Institute
Submitted to the Department of Nuclear Engineering
in partial fulfillment of the requirements for the Degree of
Master of Science in Nuclear Engineering
at the
Massachusetts Institute of Technology
September 1999
© 1999 Massachusetts Institute of Technology
All rights reserved.
Signature of Author ................... ......................
Department of Nuclear Engineering
August 30, 1999
Certified by ....... ............ .. .... ... ....... .... . .........
Jacquelyn C. Yanch
Associate Professor of Nuclear Engineering
Thesis Supervisor
R e vie w e d by ....... . ................ ... ............... ........... ............................
Otto K. Harling
Ffessor of Nuclear Engineering
_,.,Thesis Reader
A cce pted by .......................... . . .................... ..............
Sow-Hsin Chen
Chairman, Department Committee on Graduate Studies
MABSACHUSETTS INSTITUTE
:LIRE
SO.n
Fast Neutron Relative Biological Effectiveness Determination via Proton
Bombardment of V79 Cells
by
Mark Andrew Sitek
Submitted to the Department of Nuclear Engineering
on August 31, 1999 in partial fulfillment of the
requirements for the Degree of Master of Science in
Nuclear Engineering
ABSTRACT
Conclusive data relating to the relative biological effectiveness (RBE) of the
fast neutrons encountered in neutron capture therapies are scarce. At the
Massachusetts Institute of Technology's (MIT) Laboratory for Accelerator Beam
Applications (LABA), an approach to determining fast neutron RBEs is being
developed which uses monoenergetic proton beams to simulate the recoil
protons created following elastic collisions of neutrons in tissue. V79 cells are
plated directly onto 7.5 micron thick Kapton windows which also serve as the
vacuum window for the accelerator beam port. The high current tandem
electrostatic accelerator at MIT LABA is used to accelerate protons to various
energies, which after passing through the 7.5 micron thick Kapton window,
irradiate the cells at the desired energies. Proton beams of 94 ± 20 keV, 250 ±
18 keV, 390 ± 20 keV, and 1.2 ± 0.04 MeV have been used to irradiate the V79
cells to various levels of survival. Dose rates of approximately 0.5 ± 0.05 Gy/s
are generated based on accelerator beam currents of 3.6 ± 0.2 pA. The mass
used in the calculation of absorbed dose to the V79 cells is determined by using
either: 1. the cell thickness based on the range of the proton in a cell; or 2. the
entire cell mass. Proton RBEs have been determined using four different levels
of survival and 250 kVp x-rays as a reference radiation. RBE values at the ten
percent survival of 2.6 0.6, 3.1 ± 0.4, 3.9 0.8, and 2.4 ± 0.5 have been
determined for 94 keV, 250 keV, 390 keV, and 1.2 MeV protons, respectively.
An RBE of 3.0 ± 0.9 has been determined for 1.2 MeV neutrons at the ten
percent survival level. The method of determining the cell mass for the purpose
of calculating the absorbed dose has the greatest effect on the proton RBEs.
The RBEs from the irradiation of 94 keV protons increase by seventy percent,
while those associated with 250 keV protons increase by thirty-six percent, when
the entire cell mass is used.
Thesis Supervisor: Jacquelyn C. Yanch
Title: Associate Professor of Nuclear Engineering
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I Introduction
A complete understanding of the radiobiology of neutrons over their entire
energy range is lacking. In particular, relative biological effectiveness (RBE)
values are not well known for all neutron energies. RBE is defined as the ratio of
the dose from a reference radiation to the dose from a test radiation to result in
the same biological effect in a given system. RBE values exist for both thermal
neutron beams (<0.4 eV) and the high energy beams (several MeV) utilized in
fast neutron radiotherapy [Coderre and Morris 1999, Hall 1994]. However,
conclusive data relating to the relative biological effectiveness of the fast
neutrons (-10keV to -2MeV) encountered in neutron capture therapies are
particularly limited. Moreover, the data usually used to represent this energy
range were generally generated from photon contaminated, non-monoenergetic
neutron beams from various neutron sources, such as nuclear reactors and
accelerator-based neutron producing reactions [Hall et al. 1975, Morgan et al.
1986, Geard 1996, Alpen 1991]. At the Massachusetts Institute of Technology's
(MIT) Laboratory for Accelerator Beam Applications (LABA), experimental
determination of fast neutron RBEs is being investigated through the use of
monoenergetic proton beams to simulate the recoil protons created following
elastic collisions of neutrons in tissue. RBEs of these simulated proton recoils of
various energies are determined for V79 cells at various levels of survival with
250 kVp x-rays as the reference radiation. Then, for a given neutron energy,
RBE can be determined by integrating over the RBEs of the protons present in
the neutron's proton recoil spectrum. The various RBEs determined for protons
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of four different energies of 94 keV, 250 keV, 391 keV, and 1.2 MeV will be
presented. These values are compared to those reported by other researchers.
In addition, a detailed description of the development of the proton irradiation
technique will be presented, including: 1. the ability to obtain a low current, low
energy proton beam uniformly over an irradiation area of 75 mm 2 ; 2. finding a
material compatible with cell growth to also serve as a vacuum window; 3.
establishing a suitable irradiation procedure and geometry; and 4. how to
determine the dose being delivered to the V79 cells via extremely short-range (1-
50 microns) particles.
1.1 Application to Boron Neutron Capture Therapy
Boron Neutron Capture Therapy (BNCT) is an experimental, binary cancer
treatment modality that seeks to combine boron and thermal neutrons to
selectively irradiate neoplastic tissue. The use of thermal neutrons and boron-10
separately does not cause significant damage to tumors or healthy tissue, but
when combined inside a tumor, the short range, high energy particles of the
'
0B(na)7Li reaction can result in significant tumor cell killing while leaving the
healthy tissue untouched. Early clinical trials on malignant gliomas at
Brookhaven National Laboratory and MIT utilized thermal neutron beams from
their respective nuclear reactors by reflecting the scalp to expose the brain so
that the thermal neutrons can directly irradiate the tumor [Coderre and Morris
1999]. However, the thermal neutrons were poorly penetrating and excessive
scalp damage resulted when deep tumors were treated. Moderation and
9
filtration of nuclear reactor beams allowed for the development of epithermal
neutron beams (0.4 eV - 10keV) [Coderre and Morris 1999]. The use of
epithermal beams allowed for deep tumors to be treated without exposing the
brain. The epithermal neutrons are thermalized before they reach the tumor by
interacting with healthy tissue. These epithermal beams, however, are generally
contaminated with fast neutrons which also interact with and harm healthy tissue
[Coderre and Morris 1999]. The dose resulting from fast neutrons is highest at
the surface of the skin and exponentially decreases with depth as the beam is
attenuated by healthy tissue. Obtaining the RBEs of these fast neutrons will
allow the neutron dose to be expressed in photon-equivalent units, which enable
the neutron doses to tumor and healthy tissue to be compared to traditional
photon irradiation [Coderre and Morris 1999]. In order to make the units
equivalent, the physical dose is merely multiplied by the RBE. With all the
radiation components of BNCT normalized to a common unit, the treatment
planning software for clinical BNCT can then consider the dose components of
each radiation together to provide more accurate dose profiles. This allows
physicians to make more informed decisions as to the appropriate beams and
doses to use for treating a particular tumor. In addition, the healthy tissue effects
at the epithermal neutron beam entrance into the body as a result of the fast
neutron contamination in the beam will be better understood and characterized
due to the reduced uncertainty in the RBEs. Knowing the healthy tissue effects
may allow for the quality of the neutron beam to be compromised in favor of
higher dose rates, and thus shorter treatment times, up to the limiting effect in
10
the healthy tissue. For instance, a neutron beam contaminated with fast
neutrons [and a higher dose rate as a result] can be used to shorten treatment
times because the healthy tissue effects would have been well characterized for
that particular neutron beam because the neutron RBEs are known.
1.2 Current Proton and Fast Neutron RBE Knowledge
The quest to determine fast neutron RBEs has prompted researchers over the
years to adopt many different and unique approaches. Various neutron sources
from filtered nuclear reactor beams to accelerator based neutron producing
reactions have been utilized over a broad range of neutron energies. Other
groups have attempted to calculate these RBEs from proton recoil linear energy
transfer (LET) data. The RBEs determined by these various groups have been
for several different endpoints in various biological systems from small rodents to
various experimental cell lines. An attempt here is made to summarize and
consolidate the work done to date to determine fast neutron RBEs. Also, since
the approach of the work presented in this thesis is to determine neutron RBEs
through the simulation of proton recoil RBEs, the current knowledge associated
with the RBE and radiobiology of protons will be presented, where applicable.
1.2.1 Fast Neutron RBE Knowledge
Most of the data resulting from the earliest experimental work on fast neutron
RBEs is mainly inconclusive due to the fact that the neutron beams contained a
broad spectrum of energies [Hall et al. 1975].
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While still plagued by a somewhat broad spectrum of neutron energies, Hall et
al. were able to develop a relationship between RBE and neutron energy [Hall et
al. 1975]. Nine neutron energies from 110 keV to 15 MeV were studied using
V79 cells and 250 kVp x-rays as the reference radiation. The eight neutron
energies from 15 MeV down to 220 keV were created mainly from p-T reactions
using a van de Graaff accelerator, where the energy spread in the neutron
beams ranged from ± 4% for the highest energy up to ±28% for the lowest
energy. The 110 keV neutron spectrum that was used had an energy spread
from 0 to 110 keV. The spread in the neutron energies is a result of the angular
dependence of the energy of these neutrons when they are created by the p-T
reaction. The angular spread in the beam as it reaches the biological target
cannot be avoided due to the finite solid angle of the irradiation dish and as a
result, a spectrum of neutron energies will be present. RBEs were determined for
four levels of survival (0.8, 0.37, 0.1, and 0.01) for all neutron energies available.
The resulting RBE curves as a function of neutron energy for each level of
survival are presented in Figure 1-1.
12
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Figure 1-1: RBE as a function of neutron energy as developed by Hall et al.
RBE values were calculated at four levels of V79 cell survival 80, 37, 10,
and 1% [Hall et al 1975].
The curves are all sigmoidal in shape and suggest that neutrons in the energy
range of 340 keV to 350 keV are the most biologically effective. At this neutron
energy range, RBE ranged from approximately 11 for 80 percent survival as the
end point down to about 4 for one percent survival.
While Hall et al. developed RBE values over a broad range of energies,
Morgan et al. attempted to determine RBE for a much lower, single neutron
energy of 24 keV [Morgan et al. 1986]. Specifically, an iron-filtered beam from
the PLUTO research reactor with a peak neutron energy of 24 keV (93% of the
neutrons were at this energy) was utilized. Cell survival in HeLa and V79 cells
was used as the end-point with RBEs at 37 percent survival determined to be 5.8
±0.8 for the HeLa cells and 3.14± 1.1 for the V79 cells, with 6Co gamma rays
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as the reference radiation. The RBEs of 250 kVp x-rays when 60Co gamma rays
are used as a reference are in the range 1.1 to 1.5, over a wide range of
surviving fractions'. Unfortunately, the RBEs obtained were not solely for the 24
keV neutrons. Since the beam originated from a nuclear reactor, it was
contaminated with reactor core photons and those photons created in the reactor
structural material itself. The photon dose rate did not exceed 15% of the
beam's total dose rate [Perks et al. 1988].
Ngo et al. obtained RBE values for the two cyclotron-produced fast neutron
beam spectra from the 43-MeV protons on beryllium reaction and the 25 MeV
deuterons on beryllium reaction [Ngo et al. 1991]. Survival of V79 cells was
used as the end point with 60CO gamma rays as the reference radiation. The
RBE values at 50 and 10 percent survival were 2.53 ± 0.51 and 3.20 ± 0.74 for
the p-Be reaction and at the same levels of survival for the d-Be reaction, the
RBEs are 3.20 ± 0.74 and 2.30 ± 0.49, respectively. The precision with which
the RBEs are reported is questionable. The dose rates they report are only
significant to the first decimal place, however, their RBEs are reported to a
significance of two decimal places. Ngo et al. state that their results show that
there is a definite energy-dependent nature of RBE for fast neutrons [Ngo et al.
1991]. However, examination of the data demonstrates that all of the RBEs
reported are within uncertainty of one another.
I RBEs were determined by taking the ratio of doses at the same levels of survival for 250 kVp x-
rays and Co-60 gamma rays. The 250 kVp survival curve used in the determination of RBE is
presented in Figures 3-1 through 3-6 of Chapter 3 of this thesis. The Co-60 survival curve is
from Morgan et al., 1986.
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Alpen and Frankel have assessed RBEs as a function of neutron energies in
the range 5 keV to 5 MeV [Alpen and Frankel 1993]. Their estimates of RBEs
were generated by synthesizing tolerance doses from animal and cell line
studies from various researchers, including Broerse et al. (1967), Hall et al.
(1975), Belli et al. (1989), and a few others. This assessment of RBEs is
particularly relevant to BNCT because the RBEs are for the clinically relevant
end points of late tissue tolerance for the skin, brain, and spinal cord. The
largest RBE of 3.5 was estimated for the skin for neutrons in the energy range of
5 keV to 50 keV.
The previous RBE values described were generated from experimental,
survival curve data. Blue et al., however, calculated RBE as a function of
neutron energy for energies of interest in BCNT [Blue et al. 1993, Blue et al.
1995]. The RBEs are calculated by determining the combined proton fluence in
tissue resulting from proton recoils and the 590 keV protons from the 1N capture
of thermal neutrons. The LET of the proton distribution is then determined.
Next, the proton RBEs as a function of LET are weighted by the proton fluence
LET distribution for various neutron energies and then integrated over all LET to
determine RBE (at 10% survival in a human cell line) as a function of neutron
energy. The RBE curve is then normalized to a clinically relevant neutron RBE
from the Brookhaven Medical Research Reactor epithermal neutron beam used
for BNCT. The maximum RBE of 6.2 occurs at a neutron energy of 350 keV.
This result compares well with the RBE data compiled by Hall et al. [Hall et al.
15
1975]. The two curves generally have the same shape and the maximum RBEs
occur at the same neutron energy of 350 keV.
Geard used neutrons ranging from 230 keV to 1.91 MeV from the T(p,n)3He
reaction to look at chromosomal aberrations in Vicia faba cells [Geard 1996].
While cell survival RBE data were not generated from this work, Geard did
conclude that 320 keV neutrons are most biologically effective per unit absorbed
dose at inducing chromosomal aberrations. This conclusion, however, is in line
with the RBE experiments performed by Hall et al., 1975, where 340 keV to 350
keV neutrons were deemed most biologically effective at V79 cell kill.
1.2.2 Proton RBE Knowledge
The earliest low-energy proton RBE measurements are very limited and
pertain to many different biological systems [Larsson et al. 1959, Vainson et al.
1971, de Choudens et al. 1976]. In addition, RBE values ranging from 1 to 6 are
reported for the same LET in different experiments for different biological
systems [Larsson et al. 1959, de Choudens et al. 1976]. Since then, various
other researchers have reported proton RBEs over a wide range of energies and
LETs.
Bettega et al. determined RBEs for proton beams of 31, 12, and 8.0 MeV
using a cyclotron [Bettega et al. 1998]. Survival in the human EUE cell line was
used as the endpoint and 60Co gamma rays as the reference radiation. Various
survival curve parameters are presented as function of three proton energies and
their respective LETs. The most significant RBEs determined are for 37 percent
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survival with 0.9 ± 0.3 corresponding to the 31 ± 0.6 MeV protons, 1.2 ± 0.4 for
the 12 ± 1.2 MeV beam, and 1.5 ±0.5 for the 8 ± 1.6 MeV beam.
RBEs for two lower proton energies, 7.4 and 3.0 MeV, were investigated by
Perris et al [Perris et al. 1986]. Survival of V79 cells was used as the endpoint
with Co-60 gamma rays as the reference radiation. The results of these
experiments were consistent with those of Bettega et al., 1998, in showing that
there is a definite increase in the biological effect as proton energies decrease.
Furthermore, the RBE at 37 percent survival of 1.27 determined for the 7.4 MeV
proton beam is within the uncertainty of that RBE determined for the 8 MeV
proton beam of Bettega et al., 1998. The 3.0 MeV proton beam in this work had
an RBE of 1.95 for the 37 percent level of survival.
The RBE of lower energy protons was investigated by Folkard et al. by using
protons of 1.07, 1.83, and 3.66 MeV at the Gray Laboratory [Folkard et al. 1996].
Survival of V79 cells was used as the end-point and 240 kVp x-rays as the
reference radiation. The most significant conclusion of this work was that proton
RBEs increase with increasing LET up to a peak at an LET in the range of 55-65
keV/pm. These conclusions are drawn by combining the RBE-LET data for
protons and deuterons to create one curve because the researchers believed
that the same RBE-LET relationship can be used to describe the effects of both
protons and deuterons. The individual RBEs for 10 percent survival were 1.25,
1.40, and 1.91 for 3.66, 1.83, and 1.07 MeV proton beams. The LET values of
these proton energies were 10.1, 17.8 and 27.6 keV/pm, respectively. The RBE
values for higher LETs are derived from the deuteron beam irradiations.
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The proton RBE-LET relationship was extended to lower proton energies
through the work of Bettega et al. when they studied the inactivation of the
mouse embryo fibroblast cell line of C3H1OT1/2 [Bettega et al. 1998]. Co-60
gamma rays were used as the reference radiation. RBEs for protons of energies
3.18 to 0.72 MeV were presented as a function of LET. Consistent with Folkard
et al., 1996, an RBE of 1.6 ± 0.4 was determined at 10 percent survival for 10
keV/pm protons (-3 MeV). The two research groups are also consistent at 27
keV/pm (-1 MeV) with RBEs around 2.0.
The most recent proton RBE-LET data were generated by Belli et al. when
they looked at V79 cell inactivation due to protons in the energy range of 2.93 to
6.0 MeV and an LET range of 37.8 down to 7.7 keV/pm [Belli et al. 1998]. The
maximum RBE of 1.82 at 10 percent survival (250 kVp x-rays as the reference
radiation) was for a proton LET of 31 keV/im. The value of the RBE at the 31
keV/pm LET is consistent with both Bettega et al., 1998 and Folkard et al., 1996.
The biological effectiveness of the protons that are examined in this thesis
include those at energies of 94 keV, 250 keV, 390 keV, and 1.2 MeV. These
energies were selected because the protons vary widely in their LETs and
ranges in a cell. As seen in Table 1-1, the 94 and 250 keV protons do not pass
completely through a V79 cell, with the 94 keV proton probably not even
reaching the cell nucleus. The 390 keV protons just pass through the entire cell,
while the 1.2 MeV protons easily traverse the entire average cell thickness of 6
pLm.
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Table 1-1: Range and LET of the Experimental Protons [Ziegler 1998]
Proton Energy LET (keV/gm) Range in Cell
(keV) L1M)
94 77.59 1.61
250 60.6 3.82
390 47.6 6.43
1200 24.0 32.27
1.3 Fast Neutron Interactions with Biological Matter
All neutrons, fast and thermal, interact with matter by either being absorbed by
a target nucleus or through elastic or inelastic scattering events with the target
nucleus. The probability with which these interactions occur is represented by
the cross section as a function of neutron energy. For fast neutrons, the
dominant reaction in mammalian tissue is elastic scattering with hydrogen nuclei
['H(n,n')p]. Such nuclei are abundant in mammalian tissue because mammalian
cells are composed of between 70 and 85 percent water [Cember 1983]. The
similarity in the masses between the target hydrogen nucleus (i.e. a proton) and
the fast neutron allows for significant energy transfer from the neutron to the
hydrogen nucleus. Conservation of energy and momentum dictate that the
energy transfer will be governed by the following relationship:
4M ' mEn oE,= "2mE cos29 1(M+ m) 2
where,
19
EP= recoil target nucleus (proton)
En= incident neutron energy
0 = recoil nucleus scattering angle (laboratory frame)
m = neutron mass
M = target mass (hydrogen nucleus)
For a head on collision (0 =180), the maximum amount of energy, (the initial
energy of the incident neutron) is transferred to the proton, thus creating the
most energetic "recoil" proton.
The energy distribution of the recoil proton ranges from zero when 0 = 0 to the
maximum when 0 = 180. In principle, all scattering angles are allowed, resulting
in a continuum of possible recoil energies between the minimum and maximum
energies [Knoll, 89]. If the scattering process is isotropic in the center-of-mass
coordinate system, the differential scattering cross section is constant. This
simplifying result is not generally the case for target nuclei, but it does hold for
scattering off hydrogen nuclei when the neutron energy is below 10 MeV. The
resulting proton recoil energy distribution is rectangular in the center-of-mass
coordinate system with a minimum of zero and extending to the incident neutron
energy (see Figure 1-2) [Knoll 1989].
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Figure 1-2: The individual collision proton recoil probability distribution
expected from a neutron of energy, En, as it collides with hydrogen atoms
in tissue[Knoll 1989]
The rectangular spectrum in Figure 1-2 is generalized for one neutron for one
collision. For a beam of monoenergetic neutrons of energy En, the recoil proton
spectrum is peaked at low neutron energies. As the neutrons slow down from En
to E'n to E" to E.'" , the proton recoil spectrum begins to approach that in Figure
1-3.
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Figure 1-3: An example of the proton recoil spectrum expected in tissue
from monoenergetic neutrons of energy En.
Work by Geard using monoenergetic neutrons from the T(p,n) 3He reaction
produced the recoil proton spectra expected from monoenergetic neutrons of
1910, 430, 320, and 230 keV and the percentage contributions from each energy
grouping [Geard 1996. The resulting spectra look similar to that in Figure 1-3.
The "recoil" protons that are created produce their own densely ionizing path
as they continuously slow down via elastic collisions with atomic electrons. The
inelastic collisions between the proton and the target atom results in either
excitation of the atom or in ionization which usually leaves the atom in an excited
state. For the neutron energies of interest for this work, bremsstrahlung as an
energy loss mechanism does not apply because the protons that are created do
not have sufficient energy to create a significant number of bremsstrahlung
photons.
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For the energetic protons created when fast neutrons slow down, the
creation of energetic electrons, characteristic x-rays, and lower energy photons
contributes to the transport of energy away from the proton's trajectory. High and
low electrons can be created from either the direct ionization of the atom, which
occurs when energy is transferred from the energetic proton to an atomic
electron, or when the atom is in an excited state and de-excites by transferring
the energy to an atomic electron. The secondary electrons that result from direct
ionization of the atom are called delta rays and have enough energy to leave the
immediate vicinity of the proton's path (a 1 MeV proton creates a delta ray with a
maximum energy of 2.18 keV) and create their own ionization track, thus
depositing energy (dose) away from the proton's trajectory. Very low energy
electrons can be created which are a direct result of the de-excitation of atoms
with inner shell ionizations. Auger and Coster-Kronig electrons are ejected as a
result of radiationless electron transitions in the ionized or excited atom. Auger
electrons result when an electron moves to a more tightly bound energy position
in the atom and the excess energy released in the transition is given to a higher
shell electron causing it to be ejected from the atom. In the Coster-Kronig
transition, an electron moves to a more tightly bound position in the atom within
the same electron energy subshell, followed by the ejection of an electron from
the same or higher major shell [ICRU 1983]. Characteristic x-ray creation
competes with Auger electron production. Instead of transferring the excess
energy to an atomic electron, the excited atom can lose the energy by emitting
an x-ray characterized by the energy difference between the electron shells.
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Other low energy photons are created when excited atoms de-excite by emitting
their energy as these photons. For the low atomic number elements of tissue,
the fluorescent yield does not exceed 0.1. The fluorescent yield of an element is
defined as the number of K x-ray photons emitted per vacancy in the K energy
sub-shell [Turner 1995].
The microscopic, detailed, individual energy transfer events of protons are
generally not important for many applications. Approximations to the average
energy lost by protons, instead, are sufficient. In order to determine the average
energy lost by the proton to its surrounding medium, the quantity linear energy
transfer (LET) was developed. In 1962, the International Commission on
Radiological Units (ICRU) defined the quotient,
LET dEL [1-2]
dx
as the linear energy transfer of charged particles in medium, where dEL is the
average energy locally imparted to the medium by a charged particle of specified
energy in traversing a distance of dx [Turner 1995]. The expression, "average
energy locally imparted," was not clearly defined, allowing for different
interpretations, thus rendering LET an ill-defined quantity at times. The ICRU, in
1970, recognized the broad interpretations of LET and defined the quantity, LETA
as the "restricted stopping power" for charged particle energy losses up to, but
not exceeding A. Symbolically, the quantity is represented as the following:
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LET, = - (dEL [1-3]
This new definition of LET allows for the energy lost by the particle to be more
closely associated with the energy actually absorbed in the target by restricting
the energy transfer collisions up to A. As a result, the range of the secondary
electrons and delta rays created (which can remove energy from the volume of
interest) will be limited to the size of the biological target. A A of 10 keV will limit
the energy losses to within 2 ptm of the energy transfer event. The discrepancy
between the energy lost by the particle and the energy locally absorbed by the
medium (absorbed dose) arises when energy is transported out of the volume of
interest or away from the proton's path. For the energetic protons created when
fast neutrons slow down, the creation of the energetic electrons, characteristic x-
rays, and lower energy photons described previously account for the difference
between the two quantities.
When the subscript, A, is equal to infinity, the quantity unrestricted stopping
power is defined. Bethe was able to develop an analytic expression for
unrestricted stopping power (or mean rate of energy loss) which varies directly
with the square of the charge of the charged particle and inversely with the
particle's energy. Bethe used relativistic quantum mechanics to develop the
following expression for the unrestricted stopping power of a uniform medium for
a heavy charged particle: [Turner 1995]
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where
ko = 1/4iso = 8.99 x 109 N m2 C-2
z = atomic number of the heavy charged particle,
e = electron charge magnitude,
n = electron number density in the medium,
m = electron rest mass,
c = speed of light in vacuum (3.0 x 108 m/s),
p = v/c = speed of heavy charged particle relative to speed of light (0 / 1),
I = mean excitation energy of the medium.
Bethe's equation is only valid for protons in the energy range of 0.1 MeV up to
10 MeV. As predicted by equation 1-4, the stopping power or specific energy
loss of the proton increases as 1/E along the proton's track as it slows down.
Near the end of its track, this quantity reaches a maximum and then the proton
picks up an electron and stops having deposited all of its energy into the
medium.
The hydrogen nuclei which became recoil protons served to stop the original
fast neutrons. These thermalized neutrons then have two most probable fates in
tissue. Table 1-2 provides the details of the two possible reactions.
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Table 1-2: Most Significant Thermal Neutron Reactions with Tissue [Turner
1995]
Thermal Neutron Cross
Reaction Reaction Products Q-value Sections x 10-(cm-')
_ a __s __t
1H(n, y) in+ 1H + H + 0y 2.22 MeV 1.7 200 202
14N(n,p) 1n+ 1 N-> 14C+ lp 0.626 MeV 9.9 50 60
The 2.22 MeV gamma that is created by the 1H(n, y)2 H reaction in Table 1-2 is
of low LET and has a high probability of escaping the body, thus depositing its
energy elsewhere, away from target nuclei. As a result of this energy being
deposited away from target nuclei, its contribution to dose in a cell can be
neglected.
The 4 C atom created in the 14N(n,p) 4C reaction in Table 1-2 is fourteen times
as massive as the proton, thus most of the energy from the reaction is carried
away by the proton (590 keV on average) as determined by Equation 1-5.
E =MNQ [1-5]
mP + MN
where,
Ep = kinetic energy carried away by proton
Mc = mass of carbon (recoil nucleus)
mp = mass of proton
Q = EP + EC
This energetic proton then creates its own densely ionizing path as it slows down
in a manner exactly like the recoil protons created from fast neutron interactions
with hydrogen.
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1.4 Relative Biological Effectiveness (RBE)
Different types of radiation result in varying degrees of biological damage.
While the energy deposited per unit mass (i.e. absorbed dose) can be the same
for different types of radiation, the degree of biological damage is different. All
ionizing radiation create the same initial products of ionizations and excitations in
about the same number per unit energy imparted to a medium [ICRU 1983]. The
difference in biological damage is a result of the spatial deposition of the
particles' energy loss at the sub-cellular level, in particular at DNA dimensions
[Hall 1994]. The comparison of different types of radiation is accomplished
through the ratio termed, relative biological effectiveness (RBE). Radiation is
compared to the same reference radiation in order to compare RBE values for
different types of radiation. Traditionally, 250 kVp x-rays serve as the reference
radiation, but frequently now 60Co is used [Held 1998]. For the RBE experiments
conducted as part of this thesis, 250 kVp x-rays are used as the reference
radiation because access to such a source is available. RBE, as defined
previously, is the ratio of the dose from a reference radiation (D250) to the dose
from a test radiation (Dr) to result in the same biological effect in a given system.
Symbolically, this ratio is given by:
RBE= D 25 [1-6]
Dr
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In order to determine RBE using cell survival as the end point, a plot of cell
surviving fraction as a function of absorbed dose for the test radiation and the
reference radiation serves as the starting point.
1.4.1 Cell Survival Curves
In order to obtain the surviving fraction, a known number of cells are irradiated
to a known dose. The surviving cells are then allowed to form colonies (a colony
is a group of 50 or more cells) [Bettega et al. 1979]. The surviving colonies are
then visually counted, and after correcting for plating efficiency (cell survival with
no dose applied), the surviving fraction of the original number of cells irradiated
is determined. Equations 1-7 and 1-8 show the relationship between plating
efficiency (PE) and surviving fraction (SF).
PE = Number of colonies counted [1-7]
Number of cells plated
SF = Number of colonies [1-8]
Number of cells plated x PE
Surviving fraction as a function of dose is plotted to give a cell survival curve for
the radiation. RBEs can then be determined by taking the ratio of the doses at
various surviving fractions. Figure 1-4 illustrates this concept in general form.
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Figure 1-4: An example demonstrating how cell survival curves are used to
determine RBE. Surviving Fraction is plotted versus absorbed dose to the
biological system for two (or more) types of radiation. The RBE at the "x"
level of surviving fraction is the ratio of the dose required by Radiation 1 to
Radiation 2 to result in a surviving fraction of x. The width of the shoulder
region on the Radiation I curve is at the point where the curve begins to
straighten.
The survival curves presented in Figure 1-4 represent the linear-quadratic
relationship for cell killing. This model of cell killing assumes that there are two
components to cell killing, one directly proportional to dose and the other
proportional to the square of dose [Kellerer and Rossi 1971, Hall 1994]. Kellerer
and Rossi developed the theory of dual radiation action which is based on the
premise that at least two sub-lesions (e.g. DNA strand breaks) are needed for
inactivation of a cell [Kellerer and Rossi 1971]. These sub-lesions can be
produced by either the passage of one (component directly proportional to dose)
or two radiation tracks through a target (component proportional to the square of
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dose) [Kellerer and Rossi 1971]. Equation 1-9 shows the relationship between
cell survival and dose for this model.
S=e- 2) [1-9]
The constants a and P are the initial slope of the curve at low doses and the
slope at high doses, respectively. The dose at which the linear and quadratic
components are equal is given by the ratio, a/P. In order to determine the value
of these constants, equation 1-10 is converted to the following form:
InS PD [1-10]
D
and (In S)/D versus D is plotted to produce a as the intercept and P as the slope
of the linear fit. When a/P is small, the curve fit by Equation 1-9 is more curvy
and indicative of more densely ionizing radiation such as fast neutrons. In fact,
when the LET is high enough, the quadratic component of Equation 1-9 is
dropped, creating a linear survival curve (on a semi-logarithmic scale).
Conversely, a higher a/P is indicative of sparsely ionizing radiation, such as 250
kVp x-rays [Hall 1994]. The bend in the beginning of the sparsely ionizing
radiation surviving fraction versus dose curve (radiation 1 in Figure 1-4), is
referred to as a shoulder and is a result of the biological system's ability to repair
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itself [Hall 1994]. As a result, more (or extra) radiation is needed to reach the
same level of cell kill as is achieved with the more densely ionizing radiation.
1.4.2 Complexities of RBE
The RBE of a biological system is dependent on many factors, thus making it
a very complex quantity.
As mentioned previously, the degree of biological damage produced by a
charged particle is determined by its spatial deposition of energy which is
quantified by its LET. Therefore, RBE is a function of the radiation's LET or the
quality of the radiation. The relationship between RBE and LET is based on the
size of the DNA molecule. Experiments have shown that the DNA double helix is
the target molecule for cell inactivation [Hall 1994]. Damage to DNA molecules
can be in many forms, including double and single strand breaks, cross-linking,
base addition and deletion, and many other distortions of the molecule. The
most effective of these at causing cell death is the double strand break [Hall
1994]. Single strand breaks are a frequent occurrence, but readily repaired.
Double strand break repairs are an error prone process, thus more likely to lead
to cell death. The probability of a double strand break is directly related to the
LET of the radiation. With higher LET radiation, such as low energy protons,
which deposit energy densely along a relatively straight path, double strand
breaks are more frequent. RBE increases rapidly with increasing LET up to a
maximum. The optimal (maximum) LET for cell killing for a wide range of
mammalian cells occurs at approximately 100 keV/ptm where energy deposition
occurs every 20 A which corresponds to the diameter of the DNA [Hall 1994].
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Above the optimal LET, the radiation still inactivates the cells, but is much less
effective per unit dose because the energy deposition events occur more
frequently than needed. As a result of this over kill, the RBE decreases.
While it is true that RBE is a function of LET, it is not true that particles with
the same LET will have the same RBE. Particles with different charges and
different velocities can have the same LET. However, the particle's velocity
determines the energy distribution of the delta rays created when the particle
interacts with the medium. In many cases, it is the delta ray distribution that is a
major factor in the spatial distribution of energy [ICRU 1983].
RBE also depends on the biological system or endpoint studied. For the
same absorbed dose or even dose per fraction, RBE varies for different tissue
and cell types [Hall 1994]. The difference in RBE values is a result of the
sensitivity of cells to radiation, or more precisely, their ability to repair sub-lethal
radiation damage from x-rays. A cell's ability to repair manifests itself through
the large and variable initial shoulder in the cell survival curve. For higher LET
radiation, such as fast neutrons, this shoulder region is smaller and less variable
[Hall 1994]. As a result, for cells with a large shoulder in the x-ray survival curve,
the RBE will be greater than when there is a small shoulder.
RBE is also dependent on the absorbed dose, the fractionation of this dose
into smaller doses, and the dose rate. In general, when comparing high LET
radiation to x-rays, the RBE is larger at small doses because of the shoulder
present in the x-ray survival curve that is lacking in more densely ionizing
radiation, such as neutrons. For a fractionated dose delivery, the RBE of more
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densely ionizing radiation will be greater than that for a single exposure because
the fractionated doses are smaller and RBE is larger for smaller doses (see
Figure 1-5). This effect is a result of the x-ray shoulder repeating for each dose
fraction. The shoulder can be seen as representing dose that is wasted. The
lack of a shoulder is indicative of a more efficient cell killing radiation per unit
dose. As a consequence, RBE will increase with the number of fractions. When
the dose rate is low, the RBE of densely ionizing radiation (i.e low energy
neutrons) is larger than for an acute dose because the effectiveness of cell killing
of the densely ionizing radiation decreases with dose rate more slowly than is the
case for x-rays [Hall 1994].
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Figure 1 -5: An example from Hall demonstrating the effect of fractionation
on RIBE [Hall 1994]. Panel (A) presents the survival curves for single doses
of neutrons and x-rays. Panel (B) presents the survival curves for a
fractionated dose delivery. The shoulders in the survival curves of (A)
repeat themselves for each fraction. Since the x-ray shoulder is larger than
that for neutrons, the neutron RIBE increases from 1.5 to 2.6 at the same
level of survival.
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The data relating to the biological effectiveness of the fast neutrons
encountered in neutron capture therapies and the recoil protons that these
neutrons create have been reviewed. Understanding the biological effectiveness
of these particles will aid in more effective treatment of tumors via boron neutron
capture therapy. An attempt is made in this thesis to determine the RBEs of fast
neutrons by simulating the recoil protons that are created when these fast
neutrons slow down in tissue.
The method by which the RBE experiments are performed is described in the
next chapter. In addition, a detailed description of the various engineering and
biological challenges that were overcome will also be presented in great detail.
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2 Experimental Methods and Materials
2.1 Facility Description
The accelerator and the new biology laboratory within MIT LABA are used to
perform the experiments as part of this work. A general description of each of
these facilities is provided in the following sections.
2.1.1 MIT LABA Accelerator Facility
The MIT LABA accelerator facility contains a tandem electrostatic accelerator
capable of accelerating protons, deuterons, and most recently, alpha particles.
The accelerator is located in a room in the basement of building NW13 on the
MIT campus. The accelerator room is approximately 17 feet by 38 feet. In
addition to the accelerator itself, the room contains the power supplies for all the
accelerator's components, as well as the first sections of the exterior beam line
and a beam steering magnet [Blackburn 1997]. The accelerator is separated
from the shielded radiation vault where the experimental targets are located, by a
44" thick concrete wall [Murphy 1999]. A small circular port in the concrete wall
allows the beam tube to pass from the accelerator room into the vault for target
irradiation. A switching magnet located at the end of the accelerator directs the
beam to one of five different ports to allow for multiple experiments to be
connected to the accelerator at once. A control room is located adjacent to the
radiation vault where the accelerator is operated and experimental parameters
monitored (such as beam current on target). The two rooms are separated by a
three foot wall of concrete and a door that is made of two feet of concrete
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[Blackburn 1997]. A rough schematic of the accelerator facility is provided in
Figure 2-1.
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Figure 2-1: The MIT LABA accelerator facility showing the accelerator and
radiation vault
The tandem electrostatic accelerator at MIT LABA was designed by Newton
Scientific, Inc. and was constructed with the help of MIT LABA members. While
there are many parts and components that comprise the accelerator, three
distinct components can be identified to characterize the accelerator as a whole:
the ion-source, the injector, and the accelerating column and pressure vessel
[Blackburn 1997]. The completed accelerator, as shown in Figure 2-2, weighs
close to 1000 kg and has a total length of 4.3 meters. The largest diameter of
the pressure vessel is 0.94 meters and while supported by an adjustable
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aluminum stand, the accelerator's height reaches 1.6 meters at the highest point
on the pressure vessel [Blackburn 1997].
Figure 2-2: The MIT LABA tandem electrostatic accelerator
The accelerator is designed to produce protons or deuterons with energies up
to 4.1 MeV at beam currents up to 4 mA with total power levels not exceeding 10
kW [Howard 1996]. As of this work, these design parameters have not been
achieved; however, significant progress has been made. Proton beam currents
exceeding 1 mA have been reliably achieved at 1.5 MeV [Gierga 1999].
Deuteron beam runs have resulted in peak beam currents of 500 pA at 1.5 MeV
[Gierga 1999]. These high current runs are on-going and the results presented
here do not represent limitations of the accelerator. In August 1998, the
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accelerator's ability to produce a low current alpha particle beam was
demonstrated when 0.25 pA of current at 1.5 MeV was achieved on target.
The LABA accelerator is controlled by a dedicated personal computer located
in the control room. A software controlled interface allows for various accelerator
parameters to be controlled, such as beam steering and focusing, gas flow, ion
extraction voltages, and beam energy. A series of door interlocks must be
engaged before the accelerator can be operated. A general explanation as to
how the accelerator produces a charged particle beam follows [Howard 1997,
Blackburn 1997]. A more detailed explanation of the proton beam used in this
work will be presented in a future section.
The MIT LABA accelerator produces a charged particle beam by accelerating
a charged particle through two stages (one low and one high) of acceleration by
creating a high-voltage electrostatic field on a voltage terminal in the middle of
the acceleration tube in the pressure vessel [Blackburn 1997]. The two ends of
the acceleration tube are maintained at ground potential to create the two
stages. The voltage existing on the terminal is linearly distributed along the
aluminum electrodes that comprise each stage of the acceleration column
[Howard 1996]. The low energy stage has 47 electrodes while the high energy
stage has 52. In order to accelerate particles through these stages, hydrogen,
deuterium, or helium gas must first be injected into the ion source to create
negative ions. The electrons needed to create the negative ions are created by
being boiled off a tungsten filament in the ion source. The newly created ions,
for example H~ (for protons), are then extracted from the ion source into the
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injector where they are injected into the first stage of the accelerating column via
an acceleration electrode. These negative ions are attracted to the positively
charged high voltage terminal. If the terminal is set to 1 MV, for example, the
particle will be accelerated to a kinetic energy of 1 MeV by the time it reaches the
terminal. In order for the particle to be accelerated through the second stage, it
must first be transformed into a positive ion. This conversion is achieved by
passing the beam through a very thin carbon stripping foil that removes the
electrons. In the, case of creating a proton beam, the H- becomes H+ at this
point. The newly created positive ion is then accelerated through the second
stage because of the repulsive force created by the positively charged terminal.
As the particle goes from the terminal to the end of the second accelerating
column (at ground potential), it obtains an additional 1 MeV in kinetic energy
resulting in a 2 MeV proton beam. The final kinetic energy of the beam is always
equal to two times the terminal voltage. Prior to and after exiting the
acceleration column, the beam is focused and steered by adjusting voltages on
various lenses, magnets, and electrodes. Before the beam enters the
accelerating column, horizontal and vertical steering electrodes exist to steer the
beam into the acceleration column.
In creating the heavy charged particle beam with this accelerator, secondary
electrons are created and must be suppressed. If unsuppressed, these
electrons will create intense bremsstrahlung radiation when they are accelerated
and when they collide with the accelerator pressure vessel and other accelerator
components. This bremsstrahlung will result in a radiation hazard to humans
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and damage to accelerator components. A series of samarium-cobalt magnets
in the accelerating columns is used to suppress these electrons by deflecting
them out of the beam [Howard 1997]. The heavy ions experience a negligible
deflection and remain in the accelerating column as desired.
2.1.2 MIT LABA Biology Laboratory
The MIT LABA biology laboratory is located in the basement of building NW13
on the MIT campus. The laboratory was established in March 1998 in order to
expand LABA's scope and capabilities into cell biology. The ability of the
accelerator to create proton, deuteron, alpha particle, and neutron (via charged
particle reactions) beams coupled with the cell biology capabilities of LABA
allows for an array of new experiments to be developed centered on
characterizing the biological effectiveness of various radiation beams.
In order to effectively create and maintain a viable biology laboratory, an
established laboratory at the Massachusetts General Hospital (MGH),
Department of Radiation Oncology was used as a model [Held 1998]. The
professionals in the MGH laboratory were consulted on all matters pertaining to
the MIT LABA laboratory. First-hand knowledge of the necessary equipment and
its operation was obtained by performing simple routine cell biology tasks at the
MGH laboratory.
The major components of the cell biology laboratory consist of a biological
safety cabinet (or flow hood), a water jacketed CO 2 incubator, 4 *C refrigerators,
an inverted microscope, and a water bath. Most of these components can be
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viewed in Figures 2-3 and 2-4 which provide the layout of the MIT LABA biology
laboratory. The inherently large amounts of dust present in the room requires
that the area (especially the work bench) be cleaned at least every two weeks.
The actual components that comprise the biology laboratory are located in the
most sterile part of the room.
Figure 2-3: The MIT LABA biology laboratory depicting the biological
safety cabinet (or flow hood), an inverted microscope, and a water bath.
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Figure 2-4: The MIT LABA biology laboratory depicting the water jacketed
CO 2 incubator and two 4 *C refrigerators. These components are situated
to the right (facing) of the biological safety cabinet depicted in Figure 2-3.
The microscope that is used in the laboratory is inverted, meaning the light
source shines down onto the sample, as opposed to from underneath. In
addition, the magnifying lenses are underneath the sample. This type of
microscope is necessary because the cells that are used in the experiments
attach to the bottom of flasks and dishes. Trying to view the cells from above
would be very difficult because the growth medium which covers the cells would
impede the view. The inverted microscope used in the laboratory is the
Invertocon-IQ, which can be seen in Figure 2-5. The magnification capability of
the microscope is dictated by the combination of the eyepieces and objective
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lenses. The eyepieces used with this microscope consist of a pair of high
performance wide field 1OX magnification ones and one measuring, focusable
15X magnification eyepiece. The high performance wide field 1OX eyepieces
were used through this work. The four objective lenses that complement the
eyepieces reside on a quadrupole turret with precision click stops. The lenses
have magnifications of 2.5X, 5X, 1OX, and 20X.
Figure 2-5: A photograph of the Invertocon-IQ inverted microscope used at
the MIT LABA biology laboratory.
The two components that are the cornerstone of the laboratory, the flow hood
and the incubator, are described in great detail in the Appendix.
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2.2 Proton Beam Development
2.2.1 Low Current, Low Energy Uniform Proton Beam
The Newton Scientific, Inc. tandem electrostatic accelerator at MIT LABA (as
described in section 2.1.1.1) is utilized to accelerate protons to the desired
energies and currents. The current of the accelerator beam needs to be in the
picoampere range to irradiate the cells to absorbed doses in the range of 1 to 10
Gray. Normally, the accelerator is operated at much higher currents (VA to mA)
and, as a result, the operating parameters are well characterized at those
currents. Little or no empirical data on the accelerator's operating parameters
existed for protons in the picoampere range.
The ultra-low picoampere currents of the variable energy accelerator are
generated by allowing protons to leak out of the accelerator's ion source at
currents on the order of hundreds of nanoamperes. In other words, the
extraction electrode is set to zero volts [actually the electrode is set to slightly
above zero volts (0.1 keV) because for some unexplainable reason, ion
extraction is at a minimum at this value as opposed to at zero volts. [Gierga
1999]. Further current reduction is achieved by defocusing the beam before it
reaches the acceleration column and after the beam is extracted from the ion
source. The quadrupole doublet that is normally used for focusing after the beam
exits is not used in order to maintain a diffuse beam and hence a low current
density on the target at the end of the acceleration beam tube. To measure such
low beam currents, the Keithley Model 617 electrometer capable of measuring
picoamperes of beam current is used.
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To ensure beam uniformity, the beam is first centered and focused, then
defocused and diffused. The switching magnet at the end of the accelerator in
the radiation vault is the primary mechanism used to center the beam. The
current on target is first peaked by using the switching magnet, alone. Then, the
vertical steering electrode of the accelerator is used to further peak the current
on target. The horizontal steering electrode is not used because it did not affect
the current on target when it was used. With the beam centered and focused,
the diffusion and defocusing process begins by manipulating the acceleration
and focusing electrodes of the accelerator until the desired current on target is
achieved. These centering and focusing and then defocusing steps are
important because they ensure that the center or most uniform part of the beam
is striking the cells as opposed to the edge of the beam, the intensity of which is
unstable and non-uniform.
2.2.2 Beam Uniformity Measurements
A uniform beam is needed to ensure that all of the target cells receive the
same dose. Merely measuring the beam current over the target area of
approximately 75 mm2 does not provide beam uniformity information because
local current minima or maxima on the target will not be evident. In order to
examine beam uniformity accurately, a high spatial resolution medium is desired
to extract these local minima and maxima. A customized version of GafChromic
film, type MD-55 has such a high spatial resolution and as a result is used to
verify beam uniformity.
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2.2.2.1 Radiochromic Film
2.2.2.1.1 General Description
Radiochromic dosimetry involves the direct coloration of a material through
the absorption of ionizing radiation without the need for thermal, optical, or
chemical development [Niroomand-Rad et al. 1998, McLaughlin et al. 1996].
There are various types of radiochromic dosimeters in the form of thin and thick
films, gels, and liquid solutions that operate on the same general principle of
color change, but differ in their chemistry. Radiochromic films have emerged as
the dosimeter of choice in many medical applications such as brachytherapy,
stereotactic radiosurgery, ophthalmic applicators, proton dosimetry and many
others [Niroomand-Rad et al. 1998]. Radiochromic film has become widely used
due to its very high image resolution (greater than 1200 lines/mm) and its ability
to be used over a wide range of absorbed doses (10-2 to 106 Gy) [Niroomand-
Rad et al. 1998, McLaughlin et al. 1996]. The two commercially available
versions of radiochromic film that are used for medical applications are
GafChromic MD-55 and GafChromic HD-810 which were developed by
International Specialty Products, Inc. (ISP) [Donahue 1998].
2.2.2.1.2 GafChromic Film Characteristics
GafChromic film consists of a thin, transparent coating of a fine
polycrystalline, substituted-diacetylene sensor (or active) layer on a transparent
polyester film base [Niroomand-Rad et al. 1998, McLaughlin et al. 1996]. The
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active layer is made of colorless organic microcrystals of a radiation-sensitive
monomer uniformly dispersed in a gelatin binder [Niroomand-Rad et al. 1998].
The sensitive layer of the film has an atomic composition in the following
proportions by mass: 0.099 H; 0.606 C; 0.112 N; and 0.193 0, making it near
tissue equivalent' [McLaughlin et al. 1996]. The film responds to ultraviolet light
and to ionizing radiation by turning blue. The radiation-induced color change in
these films arises from the partial, solid-state polymerization of the radiation-
sensitive monomers that, when irradiated, form main-chain polyconjugated
polymers [Niroomand-Rad et al. 1998, McLaughlin et al. 1996]. The deepness of
blue is proportional to the radiation dose and arises from the progressive 1,4-
trans additions which creates the colored, polyconjugated, ladder-like polymer
chains [Niroomand-Rad et al. 1998]. The original blue image is stable up to a
temperature of 60 0C, beyond which it turns suddenly to red [McLaughlin et al.
1996].
2.2.2.1.3 Custom GafChromic Dosimeter
The GafChromic dosimetry media used for the proton experiments is one not
commercially available. The need for specialized film is a direct result of the
limited range of the low energy protons used in the experiments. The
commercially available versions of the film, GafChromic MD-55 and GafChromic
HD-81 0, have a protective covering over the active layer of the film. Tables 2-1
and 2-2 show the structures and compositions of the various GafChromic films.
The atomic composition of soft tissue in proportions of mass are: 0.103 H; 0.678 0; 0.187 C;
and 0.031 N [Turner 1995].
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Table 2-1: Radiochromic Film Structures [Niroomand-Rad et al. 1998,
Donahue 1998]
HD-810 MD-55 Custom Version
Abrasion Resistance Polyester Base - 67 gm Sensitive Layer - 20 pim
Coating - 0.75 gm Sensitive Layer - 15 gm Polyester Base - 67 gm
Sensitive Layer - 7 pm Adhesive Layer - 44.5 pm
Adhesive Layer - 1.5 pm Polyester Base - 25 pm Total Thickness - 86.25 pm
Conductive Layer - 0.05 pm Adhesive Layer - 44.5 pm
Polyester Base - 99 pim Sensitive Layer - 15 pm
Total Thickness - 108.3 pm Polyester Base - 67 
m
Total Thickness - 278 pm
Table 2-2: Radiochromic Film Atomic Composition [Niroomand-Rad et al.
1998] The percentages given in this table are approximate.
Polyester Base Sensitive Layer Adhesive Layer
Carbon: 45 atomic % Carbon: 31 atomic % Carbon: 33 atomic %
Hydrogen: 36 atomic % Hydrogen: 56 atomic % Hydrogen: 50 atomic %
Oxygen: 19 atomic % Oxygen: 8 atomic % Oxygen: 17 atomic %
Nitrogen: 5 atomic %
The experimental GafChromic material used are similar to one-half of
GafChromic MD-55, but with a slightly thicker coating of active material and none
of the lamination carrier and adhesive. Furthermore, these films lack the surface
coating for abrasion resistance that is typically used on GafChromic HD-810.
The exact structure of the film consists of approximately 20 microns of active
material coated onto a 67 pm polyester base. As a result, the low energy
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protons interact directly with the active layer of the film. The various coatings
normally used in these types of film would either completely stop the protons of
interest or greatly straggle the incident proton energy to the active layer of the
film. The direct interaction of the protons with the film's active layer allows for a
true indication of the response of the film to monoenergetic protons.
2.2.2.1.4 Radiochromic Film Handling Procedures
The fragile nature of the customized film requires special and delicate
handling procedures to be followed [Donahue 1998]. The film should be stored
at 4 0C in a light proof envelope until just prior to use [Stevens 1996]. When
handling the film, cotton gloves should be used in subdued lighting. The
ultraviolet light given off by fluorescent lighting tends to slowly expose the film. If
the exposure from the ultraviolet light is not uniform or saturates the film, then
the accuracy of the beam uniformity measurements will be compromised. The
film however, is insensitive to visible light. Unnecessary bending and flexing of
the film should be avoided because the sensitive layer can be easily marked
indelibly. In addition, the active surface where the measurement is to be
recorded should not be touched because it is extremely soft and can be abraded
very easily. When cutting the film for use in experiments, a single-edged razor
blade and a straightedge should be used with the coated or sensitive layer side
face down. The sensitive layer side can be identified by the fact that it will not
condense water vapor from your breath, unlike the polyester base side. Also,
the radiochromic film sheet tends to curl. The sensitive side is on the inside of
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the curl. Overall, the two most important things to be conscious of when using
the film are to keep it out of ultraviolet light and to not touch or mar the area of
the film where the measurement is to be taken.
2.2.2.1.5 Mounting of Film
The film must be mounted in such a way that it can be attached to the end of the
accelerator beam port. The film is mounted on to 18-8 stainless steel fender
washers by using an adhesive spray (this process will be described in further
detail in section 2.4.2.1). The mounted washers are allowed to dry for at least
twenty-four hours at room temperature in the dark. The combined film/washers
are then separated and placed into individual 60 x 15 mm tissue culture dishes
for ease of handling and to prevent inadvertent marring of the film.
In order to mount the combined washer/film assembly onto the accelerator
beam port, the same o-ring assembly that is used to mount the Kapton/washer
assembly (as will be described in Section 2.4) is used.
2.2.2.2 Beam Exposure
The accelerator settings and the beam parameters are set to values used in
the cell irradiation experiments (see Section 2.6). With the desired settings, the
film assembly is mounted onto the end of the accelerator beam port by opening
the manual gate valve in Figure 2-13. Prior to mounting the assembly on the
beam port, the assemblies are stored in the dark to prevent unnecessary
exposure. The film is then irradiated (in the dark also) at the desired proton
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energies and currents. The proton energies and currents used spanned the
range of those that are used for the cell irradiations. Once irradiated, the films
are stored at room temperature in the dark for forty-eight hours prior to analyzing
to allow the color change to stabilize [McLaughlin et al. 1996, Niroomand-Rad et
al. 1998, Stevens et al. 1996].
2.2.2.3 Film Analysis
In order to analyze the color change intensity of the film (and hence beam
uniformity), the colored area on the film is converted into a digital image via a
document scanner as described by Stevens et al. [Stevens et al. 1996]. The
scanner used is the Microtek ScanMaker X6. The scanner allows the user to
define an image resolution of up to 1400 dots/inch; however, the scanning time
at this resolution is on the order of an hour. As a result, a resolution of 720
dots/inch is used which is almost three times that used by Stevens et al. The
scanner has the capability of producing color images, but Stevens et al. found
that black and white images are smoother. As a result, black and white images
are produced in 256 element grey-scale, where a scanner signal of 256
corresponds to a white object and 1 to a black object. The software program,
Microtek Scan Suite Version 1.1, was used to drive the scanner and produce the
scanned image. All contrast and enhancement features used by the software
were turned-off as recommended by Stevens et al. so as to not alter the image
from its true color as produced by the proton beam [Stevens et al. 1996]. The
images were saved in tagged image format (or .tif). Other image format files
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such as .jpg, .gif, and bitmap were tested and no discernible difference among
the formats was identified for the purposes of this work. The saved images
were then converted into the .abd' format to allow the image to be analyzed by
the image processing software, SimVIEW, version 2.1. This software has a
feature that plots the relative pixel intensity across the image of the irradiated
film. Thus, information regarding the uniformity of the radiation exposure and
hence the beam uniformity can be extracted. Figure 2-6 shows such a plot for a
625 keV proton beam [a 94 keV proton beam to the cells after passing through
the Kapton] that irradiated a piece of film to a beam fluence corresponding to a
measured charge of 1430 pC. The plot shows that the beam is uniform within
ten percent.
1 This image format was developed by A. Dobrzeniecki, a former research scientist of MIT.
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Figure 2-6: A SIMView-generated profile on the image obtained using
GafChromic film irradiated with a 625 keV proton beam at a beam fluence
corresponding to a measured charge of 1430 pC.
2.3 Cell Biology Aspects
Developing, measuring, and testing an appropriate proton delivery mechanism
via the tandem accelerator is only one-half of the work necessary in determining
RBEs. Selecting an appropriate biological test subject is the second half.
Ideally, an in-vivo method of determining RBEs is desired so that the effects of
the organism as a whole can be considered. Such an approach however is
certainly impractical. The extremely limited range (less than 100 microns) of the
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low energy protons used would limit the penetrability of the protons to target cells
in-vivo. Furthermore, it would be impossible to control the cell population that is
to be irradiated in-vivo. Counting and determining the surviving cells would also
make an in-vivo experiment extremely difficult. As a result of these difficulties
and impossibilities, specific tissue cell lines are used.
2.3.1 V79 Experimental Cell Line
The V79 cell line was used in the experiments described here. V79 cells are
Chinese hamster lung fibroblast cells. This cell line is created by extracting
normal Chinese hamster lung cells from healthy animals, thus creating a primary
cell culture [Lodish et al. 1995]. When these cells are first placed in culture, they
grow well and continue to double for 50-100 generations creating a lineage of
cells known as a cell strainfLodish et al. 1995]. The cell strain eventually ceases
to grow because apoptosis (cell death) is a normal feature of the maturation of
an organism. V79 cells, like some other cell types, can undergo a genetic
change that allows them to grow indefinitely or become immortal. These cells
have undergone a transformation that causes them to behave as tumor cells
[Lodish et al. 1995]. As a result, certain normal growth-regulating processes
have ceased, allowing the cells to divide indefinitely. The indefinitely growing
strain of cells then becomes a cell line [Lodish et al. 1995].
V79 cells were chosen as the test cell line for the initial experiments because
of their relatively short doubling time of 10 to 12 hours. A doubling time on this
order allows for visible cell colonies to form quickly (on the order of a week), thus
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maintaining as little time as possible between experiments. The cells' ability to
survive in relatively harsh conditions also make them ideal candidates for this
work [Held 1998]. As a result, the V79 cell line can be exposed to a large array of
new environments and materials that may be necessary to get this work to
succeed. A more detailed discussion of the cells' environment for these
experiments will be presented in a later section. Another attribute of the V79 cell
line is that the V79 cells' radioresponsiveness is well understood and
documented. In addition, various other research groups have used these cells in
both neutron and proton irradiation experiments. Overall, using the V79 cell line
allows for the development of a reliable cell irradiation method that may later be
extended to different cell lines.
2.3.2 Routine Cell Transfers
As mentioned in the previous section, the V79 cell line is immortal and will
divide indefinitely given the proper conditions. The cells need to be plated in a
sterile environment and surrounded by growth medium in the humid environment
of the incubator. They also need sufficient room to grow. Given that the cells
divide every 10 to 12 hours, it does not take more than four to five days for an
initial cell plating of 20,000 cells to fill and crowd the bottom of a T175 flask (area
of 75 cm2). Once the cells become over crowded, they become confluent and
begin to detach from their growth surface. In order to prevent confluence and
maintain the cell line, the cells must be split and replated at a lower density.
Throughout this work, an initial cell plating of 20,000 cells was used during
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routine cell transfers. To ensure that the cell line has not been contaminated
and that the cells are generally stable, the cells should be counted at each
transfer in order to check the cell doubling time. Cell counting is described in
greater detail, along with the procedure that is followed to perform routine cell
transfers, in Section 2.6.
2.3.3 Cell Growth Medium Preparation and Contents
For all cell manipulations and experiments, Eagles minimum essential
medium (MEM) supplemented with the pH indicator, phenyl-red, is used as the
cell growth medium base. The MEM contains several essential amino acids,
including cytesine, glutamine, and tyrosine. The medium also contains other
essential components including; vitamins, which the cells cannot make in
adequate amounts; various salts; and glucose [Lodish et al. 1995]. Using sterile
technique, in the flow hood, 440 mL of MEM is added to an autoclaved 500 mL
Pyrex bottle. In order for the cells to gain important nutrients, the cell growth
medium should be ten percent fetal bovine (calf) serum (FCS). Serum is the
non-cellular part of the blood that is a mixture of hundreds of proteins containing
various factors needed for the successful proliferation of cells in culture [Lodish
1995]. The MEM in the 500 mL bottle is supplemented with 50 mL of FCS to
provide the proper concentration. The medium must also contain one percent
penicillin-streptomycin solution (5 mL added to 500 mL bottle) to serve as an
anti-contamination agent. The final component of the cell growth medium is 10
mM Hepes buffer which is 5 mL of a 1 M stock solution [Held 1998]. The Hepes
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serves to help maintain the pH of the medium at 7.0. The medium is stored in a
4 0C refrigerator while not in use.
2.4 Kapton Window Development
The low energy protons used to irradiate the cells have an extremely short
range in both solid matter and air; therefore, it is necessary to have the cells as
close as possible to the monoenergetic proton beam. Placing the cells inside the
evacuated chamber of the accelerator would be ideal, but impossible, because
the cells would explode due to a lack of external pressure. The target cells must
be placed at the end of the accelerator beam port on the atmospheric side. As a
result, the cells must be directly plated onto the surface that serves as the
accelerator beam port vacuum window. A window material strong enough to
serve as a vacuum window for the accelerator and capable of allowing a
statistically significant number of cells to be plated is necessary. The limited
range of the low energy protons requires a thin window in order to minimize
energy and range straggling. However, the thickness of the window needs to be
balanced with the desired cell plating area and to be able to hold vacuum
(approximately 1.5 x 10~6 torr). The vacuum capabilities part of the window was
investigated first.
2.4.1 Vacuum Window Development
A literature and world wide web search revealed several materials that were
capable of holding vacuum over the desired area. High density materials such
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as metals were immediately eliminated because of the large degree of proton
energy and range straggling. The search then focused on polymer plastic type
materials and other low density materials. Other research groups successfully
used these types of materials as vacuum windows and cell growth substrates
[Folkard et al. 1996]. Polyimides and silicon nitrides were found to have the
greatest strength properties over a sufficient area. Table 2-3 presents a
comparison of the various mechanical properties of some of these materials.
Table 2-3: Mechanical Properties of Potential Window Materials [Stevens
1993]
Property Mylar Polyimides Silicon(Kapton and API) Sico
Young's Modulus 500,000 400,000 19.7 x 107
(psi)
Ultimate Tensile 25,000 33,500 384,000Strength (psi)
Yield Strength 15,000 13,000 190,000(psi)__ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Prior to testing the window under vacuum, rough calculations of the window's
suitability as a vacuum window were performed. The Fermi National Accelerator
Laboratory's guideline for designing thin windows for vacuum vessels was
followed. The allowable stress for a circular window is given by [Western 1993]:
1/3 0.423 2 [2-1]t
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and the deflection is:
y = 0. 66 2 a qa [2-2]
where,
t = thickness of window (inches)
a = radius of window (inches)
q = uniform pressure on window (psi)
S = allowable stress (psi)
E = Young's modulus of window material (psi)
y = window deflection (inches)
Equations 2-1 and 2-2 are only valid for flexible material circular windows such
as Mylar/Kapton and titanium/stainless steel less than 0.003" (76.2 pim) thick. In
addition, the window material must be mounted such that the window edge is
held and not fixed. In order for the window to be considered thin and Equation 2-
2 valid, the window deflection, y, must be greater than one-half the thickness of
the window (t/2). The thin window equations are only to be applied when the
pressure difference across the window is less than or equal to fifteen pounds per
square inch (psi) [Western 1993]. For the proton experiments, the greatest
pressure difference the window will experience is one atmosphere or 14.7 psi.
The allowable stress on the thin windows is the more stringent of the following
[Western 1991]:
S = 0.5 Fu [2-3]
or
S = 0.9 Fy [2-4]
where,
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S = allowable stress (psi) - same as in Equation 2-3
Fu= ultimate tensile strength
Fy = yield strength of stress to produce five percent elongation (psi).
Using the Fermilab guidelines and the mechanical properties in Table 2-3,
Mylar, Kapton, and silicon windows were evaluated over an area of 75 mm2
(minimum area needed for statistically significant number of cells to be plated).
The required minimum thicknesses (t) for the three types of materials were
obtained from equation 2-1. For Kapton and Mylar the minimum safe thickness
is calculated to be 10 pm while for silicon it is 3.37 pm.
As mentioned previously, the vacuum window needs to be very thin to
minimize proton energy and range straggling. TRIM was used to evaluate the
straggling due to the windows at the calculated thicknesses. The silicon window
was the most favorable while the Kapton and Mylar windows were almost
identical.
As calculated previously, the minimum Kapton thickness is 10 pm, however,
the intent of the Fermilab guideline is for windows that are relatively permanent
and will be exposed to repeated cycling. As will be described in Section 2.6 the
windows used for cell irradiation will be used only once per irradiation and will
only be required to hold vacuum for no more than twenty minutes. As a result,
the straggling calculations were performed for the thinner, 7.5 pm, Kapton. The
7.5 pm Kapton is the thinnest version commercially available from DuPont's High
Performance Film Division and was obtained free of charge in large quantities.
Tables 2-4 and 2-5 provide the proton energy straggling through 7.5 pm Kapton
and 3 pm silicon.
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Table 2-4: Proton Energy Straggling through 7.5 micron KaptonTM Window
(Calculations performed by TRIM [Ziegler 1998])
Energy to Window Energy to Cells Straggle Percent Straggle(keV) (keV) (keV)
604 10 9 90.00
614 25 14 56.00
625 47 16 34.04
635 70 17 24.29
645 94 17 18.09
655 117 17 14.53
675 163 17 10.43
695 205 16 7.80
795 390 18 4.62
Table 2-5: Proton Energy Straggling through 3 micron Silicon Window
(Calculations performed by TRIM [Ziegler 1998])
Energy to Window Energy to Cells Straggle Percent Straggle(keV) (keV) (keV)
313 8 4 50.00
323 16 7 43.75
333 28 9 32.14
343 44 11 25.00
353 60 12 20.00
363 79 12 15.19
373 97 13 13.40
393 132 12 9.09
444 211 12 5.69
494 281 13 4.63
595 410 16 3.90
While Kapton is a relatively strong polyimide, AP1.3, a polyimide available
from Moxtek, Inc., is available in a much smaller thickness (0.15 ptm) and
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purported by Moxtek to be stronger than Kapton. The company also has the
ability to custom make variable thickness material. Discussions with Moxtek
engineers concluded that a 3 ptm version of AP1.3 would maintain vacuum over
the desired 75 mm2 area [Nielson 1998]. Proton energy and range straggling
calculations demonstrated its superiority over 3 ptm silicon (see Table 2-6).
Table 2-6: Proton Energy Straggling through 0.15 micron AP1.3 Window
(Calculations performed by TRIM [Ziegler 1998])
Energy to Window Energy to Cells Straggle Percent
(keV) (keV) (keV) Straggle
15 4 1 25.00
25 12 1 8.33
34 19 1 5.26
44 28 1 3.57
93 74 3 4.05
112 93 3 3.23
172 155 5 3.23
The cost of $6500.00 to create the necessary number of windows is
prohibitive and not worth the reduction in energy straggling that could be
achieved, at least for preliminary experiments.
As demonstrated in Tables 2-4 and 2-5, the silicon window also has an
advantage over the 7.5 pm Kapton, in terms of proton straggling. However, like
AP1.3, silicon is not easily obtained as a large number of windows at a low cost.
The 7.5 pm Kapton on the other hand was obtained free of charge.
A comparison of some of the important characteristics of the various materials
that were considered as a window material are presented in Table 2-7.
63
Table 2-7: Characteristics of Common Thin-Film Materials [Downs 1998,
Ziegler 1998, DuPont 1998]
Characteristic Mylar Kapton HN AP1.3
Material Type Polyester Polyimide Polyimide
Molecular Formula C10H804  C22 H10N2 0 4  C2 2 H10N2 0 5
Density (g/cm3) 1.38- 1.40 1.08- 1.24 1.35- 1.45
Nominal Thickness(ptm) 2.5-6.5 7.5 0.15
E TM
2.4.2 KaptonTM Window
The 7.5 pm Kapton was selected as the cell growth surface compatible as a
vacuum window because it is readily available, inexpensive, resulted in
reasonable energy/range straggling, and is similar to Mylar in composition. The
comparison to Mylar is important because as mentioned previously, Folkard et
al. demonstrated that Mylar is capable of allowing V79 cells to attach and form
colonies. With the window material selected, testing the Kapton as a vacuum
window and as a cell growth substrate was necessary.
2.4.2.1 Composition and Construction
The KaptonTM film comes as 8 /" x 11 " sheets directly from DuPont's High
Performance Film Division. The film arrives statically charged, thus making it
very difficult to handle because it tends to attach itself to anything it touches. In
addition, it has a tendency to tear; therefore, handling of the film is limited as
64
much as possible. In order for the Kapton to serve as a vacuum window, it must
first be mounted to something rigid that can be attached to the end of the
accelerator beam port. An 18-8 stainless steel fender washer with a diameter of
37 mm, which is the approximate diameter of the accelerator's beam port at the
irradiation site, was found to be the ideal mount. The washer has an exposed
area of 75 mm2 (a 10 mm diameter hole), where a statistically significantly
number of cells may be plated for irradiation. Prior to mounting, each washer is
sterilized in a pool of 200 proof ethyl alcohol in an ultrasonic cleaner. After
drying, the washer is sprayed with a commercially available glue, Spray Mountm
and then mounted to the KaptonTm by hand pressing it onto one of the 8 Y2" x
11" sheets. To prevent against tearing of the Kapton on the washer, the side of
the washer that has rounded edges should be sprayed and used for mounting.
Once on the Kapton, the washer is given a small twist to smear the Spray Mount
to help ensure an air-tight seal between the two pieces. After twisting the
washer, the Kapton sheet is pulled straight to remove any folds or ridges that
may have formed during the mounting process. The entire mounting process is
repeated until the entire sheet is covered with washers. The assembly is then
allowed to dry for at least forty-eight hours. Periodically throughout this time, the
washers are hand pressed several times to ensure good bonding between the
washer and the Kapton. Special attention is given to the edges because this is
the area where air would have the greatest possibility of entering the vacuum
once the assembly is mounted on the accelerator beam tube; thus causing the
window to fail while it is attached to the end of the accelerator beam port. Once
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the glue has completely dried, the Kapton sheet is cut into separate windows.
The surface of each window is then cleaned with 200 proof ethyl alcohol. The lot
of windows is further sterilized by exposure to ultraviolet light in the flow hood for
at least twenty-four hours. The Kapton windows are then ready for cells. Figure
2-7 shows a completed Kapton window in a 60 x 15 mm tissue culture dish.
Figure 2-7: A Photograph of a Sterilized Kapton Window in a 60 x 15 mm
tissue culture dish ready to have cells plated on its surface
The Kapton window as it is presented in Figure 2-7, cannot be attached to the
end of the accelerator beam port. A customized mount was constructed
consisting of a metallic centering ring with one of its flanges ground down to
create a flat surface. A rubber Viton o-ring is placed around the centering ring.
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The washer window is attached to the o-ring assembly by coating the o-ring with
Dow Corning's Silicon High Vacuum Grease. Figure 2-8 presents the centering
ring and o-ring along with the entire window/o-ring assembly.
Figure 2-8: A Photograph of the Kapton Window with the centering ring and
o-ring used to mount the window on the end of the accelerator beam port.
The entire assembly fits onto the end of the accelerator beam port through the
use of the flanged part of the other side of the centering ring. Figure 2-9 shows
the assembly on the end of the accelerator beam port.
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Figure 2-9: A Photograph depicting the Kapton window on the accelerator
beam port
2.4.2.2 Cell Biology Aspects
The V79 cells plating efficiency had to be determined with the materials that
composed the Kapton washers in order to accurately develop cell survival
curves. The three main components of the Kapton washer window were
studied independently. Each window component was placed into a 100 x 20
mm tissue culture tissue and a known number of cells was plated. The cells
were plated homogeneously over the entire area of the tissue culture dish. The
washer and the Kapton were sterilized with 200 proof ethyl alcohol and ultraviolet
light prior to insertion into their respective dishes. The plating efficiency of each
component was then determined by counting the number of cell colonies that
formed as compared to the original number of cells plated. The 18-8 stainless
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steel portion had no discernible effect on cell survival, as expected, since this
type of steel is routinely used in biological applications. The Kapton alone also
had no discernible effect on cell survival. This result was also predictable given
the composition of Kapton as presented in section 2.4.1.1. The Spray Mount
adhesive alone prohibited cell colony growth after four days and also reduced
the plating efficiency from 85% to 70%. The combined stainless steel, Kapton,
and Spray Mount washer reduced the plating efficiency to 70% from 85% for a
60 x 15mm tissue culture dish. With the Kapton washer fully characterized both
biologically and as a vacuum window, cell irradiation experiments were possible.
2.4.3 Cell Attachment to Window
During irradiation the Kapton window with the cells is held vertically on the end
of the accelerator beam port. As such, the cells would tend to slide down the
face of the Kapton window in the absence of an adhesive. Two commonly used
techniques for attaching the cells to the Kapton window were investigated. The
first technique of allowing cell culture medium to incubate for twelve hours on the
Kapton window was not adopted because it proved not to be as effective as the
second technique. This second technique involves the use of a cellular
attachment protein, Cell-Tak7 [Waite 1983].
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2.4.3.1 Cell-Tak7 Adhesive General Description
The commercially available product, Cell-Tak7, is used to attach the cells to
the Kapton windows. Cell-Tak7 is a cellular attachment protein solution
consisting of approximately 1 mg of protein per milliliter of solution in 5 percent
acetic acid. The polyphenolic proteins used in the solution are extracted from
marine mussels. These proteins are composed of tandemly repeated
decapeptide units of similar amino acid sequences [Waite 1983]. The proteins
are the key component of the glue secreted by the mussel for anchoring to solid
structures. [Becton-Dickinson, 1997].
The Cell-Tak7 stock is stored at 4 0C and has a minimum shelf-life of six
months. In order to ensure superior cell attachment, the stock was replaced
every six months.
2.4.3.2 Cell-Tak7 Application to Kapton Window
The sterilized Kapton windows are cleaned again with 200 proof ethyl alcohol
and are allowed to dry completely for fifteen minutes in the flow hood. The
windows are then individually placed in sterile 60 x 15 mm tissue culture dishes.
The Cell-Tak7 can be coated on to the Kapton window by two methods: hand-
spreading and adsorption. The adsorption method was chosen because it is
more consistent and convenient. In addition, this method requires the least
amount of Cell-Tak7 per unit surface coating area [Becton-Dickinson]. The
adsorption method is based on the fact that Cell-Tak comes out of solution as its
pH is raised. As a result, the Cell-Tak spontaneously adsorbs to the first surface
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it contacts. In the case of these experiments it is the Kapton window. The Cell-
Tak coating that results is very thin and on the order of a protein monolayer. The
coating is also more uniform than it would be if the Cell-Tak were hand-spread
[Becton-Dickinson].
2.4.3.3 Basic Adsorption Coating Protocol
In order for the Cell-Tak7 to adsorb to the Kapton window it must first be
combined with a neutral buffer solution of 0.1 M sodium bicarbonate. As
recommended by the manufacturer, the buffer is set to a pH of 8.0. In preparing
the buffer solution, de-ionized, sterile water was combined with sodium
bicarbonate powder in a flow hood using sterile technique.
The next step in preparing the solution for adsorption is to determine the
amount of Cell-Tak7 to add to the buffer. As recommended by the
manufacturer, a starting density of 3.5 ptg Cell-Tak/cm2 of surface area was
used. However, the necessary amount of Cell-Tak depends on the application
and type of material coated. As a result, determining the required amount of
Cell-Tak is very much empirical. Several Cell-Tak densities were tried and it was
determined that 7.0 pg Cell-Tak/cm2 is the minimum effective density for V79
cells to attach to the Kapton that will be used during irradiation.
With the Cell-Tak density determined, it is then neutralized by adding it to the
buffer solution. The volume of the buffer solution is determined by the surface
area to be coated. The surface area of the Kapton windows is 75 mm2 . The
required volume of Cell-Tak to give the necessary coating density is 15 pL. In
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order for the combined neutralized Cell-Tak solution to coat the entire Kapton
window, the 15 iL of Cell-Tak must be added to a buffer volume of 65 1L. The
two solutions are mixed thoroughly and dispensed to the Kapton window
immediately. The solution must be dispensed within ten minutes or the Cell-Tak
will adsorb to the walls of its housing vial [Becton-Dickinson 1997].
The Kapton windows with the Cell-Tak solution are then placed in a 37 OC, 5%
C02 , humid incubator for at least twenty minutes. After incubation, the Cell-Tak
solution is aspirated off and the Kapton windows are thoroughly rinsed twice with
sterile water to remove the sodium bicarbonate. The Kapton windows are now
ready for cells to be plated on them. The coated windows can be stored for up
to two weeks at 4 *C after having air-dried [Becton-Dickinson 1997].
2.5 Dose Calculations
A very important quantity in the determination of RBEs is the physical dose
absorbed by the V79 cells. The low energies of the protons precludes the use of
conventional dosimeters, such as thimble ionization chambers, Li-F
thermoluminescent dosimeters (TLDs), and diamond detectors, that are used for
higher energy protons. The range of the low energy protons prevents them from
entering the detectors that are used for proton beams at higher energies (i.e.
therapeutic beams of hundreds of MeV). The lack of a physical dosimeter
resulted in the absorbed dose to the V79 cells being calculated.
In order to calculate the absorbed dose to the cells, both their mass and
volume are needed. Cells vary in size and therefore average cell dimensions
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were assumed. The average cell thickness was taken to be 6 microns and the
cell diameter to be 10 microns [Belli 1998]. The cells were assumed to be
composed of only water. Table 2-8 summarizes the average values used to
characterize the V79 cells.
Table 2-8: Various Average V79 Cell Characteristics [Belli 1998]
Characteristic Value
Thickness 6 ± 1.2 gm
Diameter 10 pm
Planar area 78 gm 2
Volume 3.93 x 101u cm3
Mass 3.93 x 101u g
The ion slowing down code, TRIM (Transport of Ions in Matter) [Ziegler 1998],
was used to determine the fraction of the proton energy that is deposited in the
cell volume. Dividing this energy by the cell mass in Table 2-8, allowed for the
determination of absorbed dose per particle at a given proton energy. If the
proton does not have sufficient energy (320 keV) to pass through the cell, a
different approach is used to calculate the absorbed dose. For these protons
with energies that are not great enough to pass completely through the cell, the
energy deposited is simply the initial energy of the proton. The cell mass used
for these protons is calculated based on the average range (as determined by
TRIM) of the proton at the specific energy. The range of the proton then serves
as the cell thickness which is used to calculate the mass used in the
determination of absorbed dose. With the energy deposited within the cell mass
determined, the absorbed dose (energy/mass) to the cell can be calculated per
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incident proton at a given energy. The dose deposited by a single proton is
extremely small (on the order of ptrad) and as a result it takes tens of millions of
protons to produce the necessary doses of hundreds of rad. The appropriate
beam fluence is then calculated for the desired absorbed doses as a function of
proton energy. A detailed example calculation is provided as follows:
Dose Rate = Beam Current roon(second)
Energy Deposited per Proton keV) [2-5]
Cell Mass 9g)
Cell Area
x
Current Measurement Area
The last term in Equation 2-5 takes into account the ratio of the cell area to the
area over which the beam current is measured. This ratio provides the fraction
of the measured current that actually hits a single cell, thus allowing for dose to a
cell to be correlated with the measured beam current.
The dose rate is fixed and the corresponding proton beam current is
determined. In this example, 500 keV protons are assumed to irradiate the cells
depositing 293 keV of energy as they pass through the cell. The dose rate is
fixed at 3 Gy/s.
Gy _ protons 239keV 78.54ptm 2 1.60 x 10-13 Gy [2-6]3 x x mx [2-/g
sec sec 3.93x1 10 g 4.2E8gM2 keV / g
Solving for the number of protons per second in Equation 2-6 and calculating the
resulting beam current gives:
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.protons 1.6x10-19C164,482,254 x = 26.31pA [2-7]
second proton
Thus, in order to irradiate the cells to 3 Gy, a proton beam fluence equivalent to
26.31 pC of measured charge is necessary.
Dose rates of approximately 0.5 ± 0.05 Gy/s are generated based on
accelerator beam currents on the order of 3.6 ± 0.2 pA. Figure 2-10 presents a
plot of the proton beam current required to deliver 3 Gy to the cells as a function
of proton energy. The plot can be linearly scaled for higher and lower doses.
The minimum in the plot at 360 keV represents the energy at which the protons
are no longer completely stopped in the cells.
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Figure 2-10: Accelerator beam current variation as a function of proton
energy needed for a ten second irradiation to deliver 3 Gy of dose to a 6ptm
thick V79 cell.
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2.6 Cell Irradiation Protocol
The protocol for irradiating the cells can be broken down into three distinct
parts: 1. cell preparation and plating; 2. dose delivery (irradiation) via the
accelerator; and 3. cell transfer and replating.
2.6.1 Cell Preparation and Plating
The flask of cells that was prepared for the day of the experiment should be
checked under the microscope to make sure that the cells are not confluent or
contaminated and are ready for use. All of the subsequent steps should be
performed using sterile technique in the flow hood. To begin, the 10 mL of
medium on the cell stock should be aspirated off, thus leaving behind only the
cells. Depending on the size of the flask used, varying amounts of trypsin-EDTA
are added, 2mL to a T75 flask or 4 mL to a T175 flask. The trypsin is allowed to
quickly flow over the cells and then it is aspirated off to remove any cells that
have detached from the surface of the flask and to remove any dead cells or cell
waste. Trypsin-EDTA is added to the flask to help the remaining cells detach - 1
mL to the T75 flask or 2 mL to the T175 flask. The flask is then tilted back and
forth to allow the trypsin to cover all the cells. It takes one to two minutes for
the cells to detach. Placing the flask in the incubator helps the cells to detach.
Once the cells have been allowed to detach for awhile, they are checked under
the microscope to ensure that the cells have come to the surface. After the cells
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have begun to detach, the flask is hit with the palm of the hand to further
dislodge the cells. The concentration of the cells in the flask at this point is very
high. An initial dilution of the cells is achieved by adding approximately 19 mL of
medium to the flask. Pipetting vigorously with various size pipets thoroughly
mixes the cells creating a single-cell suspension. A Pasteur pipet should be the
last one used because it has the smallest diameter and it is the easiest to
manipulate to create a drop for cell counting with the hemocytometer.
A hemocytometer is a rectangular glass device that holds a fixed volume of
medium and can therefore be used to determine cell concentrations (see Figure
2-11). One drop in each side of the hemocytometer is added to take advantage
of both halves. The cells in the four outer quadrants of both halves of the
hemocytometer are counted and the average taken. This average multiplied by
104 gives the cell concentration in the flask in cells/mL. The four outer quadrants
are divided into sixteen smaller squares and each quadrant can be identified by
a double lined border that surrounds the sixteen squares. Figure 2-12 shows a
schematic of the hemocytometer grid structure as it appears under the
microscope.
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Figure 2-11: A photograph of the hemocytometer used for cell counting to
determine unknown cell concentrations.
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Figure 2-12: A schematic of the hemocytometer grid structure as seen
under a microscope at 100 x magnification. The four 1mm x 1mm corner
squares are used to determine cell concentration.
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With the cell concentration in the flask known, the cell solution is diluted to a
concentration of 2 x 10 5 cells/ml to be used as a stock. A combination of
successive 1:10 and 1:5 dilutions are made depending on the desired cell
concentrations. The desired concentrations are driven by the need to extract
exactly 100 pL for each Kapton window regardless of the number of cells to be
plated. Volumes less than 100 p.L will not adequately cover the window,
preventing the cells from completely spreading apart from one another.
Furthermore, too little volume will dry over the course of the experiments, thus
killing the cells. Volumes greater than 100 ptL will not fit in the window and will
over flow onto the Kapton blocked by the washer.
Using a 200 pl Pipetman (a highly precise volume pipet), the desired number
of cells are plated onto the Kapton windows. The 100 pL is confined to the 75
mm2 of the Kapton that will be exposed to the proton beam.
With all the cells plated on their appropriate windows, the dishes are placed
into the incubator to allow the cells to attach. A minimum attachment time of two
hours is necessary, however, for these experiments an attachment time of three
hours is used.
After the cells have attached and before they are irradiated, a polypropylene
cap is affixed, with a small amount of Spray Mount on the cap's lip, to the Kapton
window to cover the cells. Two to three hundred microliters of medium fill the
cap to keep the cells both moist and sterile during handling and irradiation.
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2.6.2 Dose Delivery (Irradiation)
As described in Section 2.5, the dose delivered to the cells is calculated as a
function of proton energy and beam current. Thus, the first step in irradiating the
cells is to determine the current that will be irradiating the cells. An aluminum
plate mounted (epoxied) onto an 18-8 stainless steel washer is placed in the cell
window position and is used to measure the current and to set the beam to the
desired parameters. The plate is electrically isolated from the rest of the
accelerator beam tube through the use of the centering ring and o-ring
combination used for mounting the Kapton windows (see Figure 2.8). The
resistance between the plate and the beam tube is checked with a multi-meter to
ensure electrical isolation. The proton beam current striking the plate is
monitored by the Keithley Model 617 programmable electrometer. The stability of
the beam current is checked several times by setting the terminal voltage to zero
and then by directly setting the terminal to the desired energy. That process
simulates the procedure that will be followed when the window with the cells is
irradiated.
With the beam parameters set and the stability of the beam verified, the
manual gate valve is closed, the aluminum plate removed, and the cell window
assembly is affixed to the end of the accelerator beam port by opening the
manual gate valve (as seen in Figure 2-13). The air injected into the vacuum
system is pumped out within fifteen minutes. Throughout the course of the
experiments, it was noticed that the speed at which the vacuum system pumped
down was directly related to the humidity in the room. On less humid days, the
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system pumped down to 1.5 x 10 -torr in three to four minutes. On more humid
days, to reach the same pressure it would take up to twenty minutes.
Once the pressure in the system reaches approximately 1.7 x 10~ torr, the cell
irradiation process begins by setting the terminal voltage of the accelerator to the
predetermined energy. A pneumatic gate valve (millisecond closing time) is used
to control the irradiation of the cells to the desired proton fluence and hence
dose.
A more accurate way of determining the proton fluence delivered to the cells
is to measure the integrated charge (via the Keithley electrometer) of the proton
beam as it strikes the aluminum part of the stainless steel washer during cell
irradiation. This method was tried with a plain Kapton window and one with cells
and medium on the window surface. In the case of the dry window, the
electrometer registered a positive charge reading consistent with the measured
current over a set amount of time. The window with the cells and medium,
however, produced an electrometer charge reading that was initially negative
and slowly became positive. At this time it is not clear why this behavior was
observed. Since the cell irradiations are for five to ten seconds, integrating the
charge on the washer during the cell irradiations is impossible as a method for
determining the proton beam fluence delivered to the cells.
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Figure 2-13: An illustration depicting the geometry of
for the cell irradiations
the end station used
Experiments pertaining to the same proton energy are conducted on the same
day, with the same set of V79 cells and the same accelerator settings, to limit
potential fluctuations in biological response.
2.6.3 Cell Transfer and Replating
After each cell irradiation, the manual gate valve is closed and the Kapton
window is removed and immediately placed back into its 60 x 15 mm tissue
culture dish. The dish with the window is then carried back to the cell biology
laboratory and immediately placed into the flow hood. The medium that is on the
Kapton window is extracted and placed into a sterile 100 x 20 mm tissue culture
dish, leaving the attached cells behind. To verify that the cells did not slide
during irradiation, they are checked under the microscope. In order to remove
the cells from the Kapton window so that they can be plated, 100 tL of trypsin-
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EDTA is added. The window is shaken and agitated to aid the cells from
detaching from the window. Checking under the microscope verifies that the
cells have started to detach. The covered dish with the window is then placed
into the incubator for five minutes to further aid in the detachment of the cells
from the window. The window is then removed from the incubator and the
window shaken and agitated again. The trypsin on the window is pipeted several
times and the window reagitated to ensure a single cell suspension. This
process is repeated ending with the trypsin being placed in the same tissue
culture dish as the medium that was extracted prior to adding the trypsin. To
ensure that all the cells were removed from the window, several pipet washes
and agitations with medium are performed with all of the medium placed into the
same tissue culture dish as before. The tissue culture dish is then filled with 15
mL of medium and placed into the incubator to allow cell colonies to form. A
final check of the Kapton window under the microscope ensures that all cells
have been removed and plated into its new dish for colony formation. It is
possible, however, for cells to be left behind on the Kapton. As a result, the
Kapton windows are flooded with 12 mL medium and placed into the incubator to
allow any colonies to form from residual cells.
2.6.4 Cell Counting
The cells are allowed to incubate for at least seven days to allow for colony
formation among the surviving cells. The tissue culture dishes containing the
cells are not moved in any way during incubation. Each colony is supposed to
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originate from one surviving cell. Agitation of the culture dish can lead to cells
dislodging from the original colony to form their own colony, thus inflating the
estimate of surviving cells. Following colony formation, the medium in the 100 x
20 mm tissue culture dishes and in the 60 x 15 mm dishes with the Kapton
windows is drained. All dishes are then stained with Methylene Blue to
permanently affix the surviving cell colonies to the dishes and/or Kapton
windows. The cell colonies (varying in size due to the effects of radiation induced
division delay) are then visually counted to produce cell survival curves. A
sample stained 100 x 20 mm tissue culture dish is presented in Figure 2-14.
Figure 2-14: A photograph of a methylene blue stained dish of V79 cell
colonies following seven days of incubation. The 3500 original cells were
exposed to 250 keV protons and irradiated to a dose of 4 Gy.
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3 Results and Data Analysis
This chapter presents the cell survival curves generated for the four proton
energies of 94 keV, 250 keV, 390 keV, and 1.2 MeV, along with their RBEs,
generated by comparison to 250 kVp x-rays at four levels of survival. The
determination of the uncertainty associated with the survival curves and
corresponding RBEs will also be presented.
3.1 Cell Survival Curves
The four proton energy V79 cell survival curves are plotted individually in
Figures 3-1 through 3-4. In each case, the 250 kVp cell survival curve is also
shown. Figures 3-5 and 3-6 have all four proton energy survival curves plotted
together with the 250 kVp x-ray survival curve. For the 94 and 250 keV survival
curves, an additional set of data is presented which corresponds to an absorbed
dose to the cell calculated based on the entire mass of the cell as opposed to
just the mass corresponding to the range of the proton in the cell (as described
in Section 2.5). When the protons do not pass through the entire cell, the mass
into which the proton deposits its energy can be calculated based on the range
of the proton in the cell. For instance, the 94 keV protons have a range of 1.6
ptm in the cell. Thus, the mass used in the calculation of absorbed is determined
by using this range as the cell thickness as opposed to 6 pm.
The 250 kVp cell survival curve was generated at MGH using a Siemens
Stabilipan x-ray machine with a calibrated dose rate of 2.0 Gy/min [MGH staff
performed the calibration]. A known number of V79 cells is plated into 60 X 15
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mm tissue culture dishes and then irradiated to known x-ray doses. Three
dishes are irradiated for each dose point. Cell survival is then determined by
counting cell colonies and adjusting for plating efficiency as described in
Sections 1.4 and 2.6.
V79 Survival with 94 keV Protons and 250 kVp X-rays
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Figure 3-1: The cell survival curve generated when 94 ± 20 keV protons
irradiate V79 cells to several different calculated doses. The two sets of
proton data represent the absorbed dose as calculated by using (i) the cell
mass according to the range of the proton in a cell and (ii) according to the
entire cell thickness of 6 microns. For comparison and RBE determination,
cell survival with 250 kVp x-rays is also plotted. The proton data are fit to a
linear relationship in the semi-logarithmic plot.
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Figure 3-2: The cell survival curve generated when 250 ± 18 keV protons
irradiate V79 cells to several different calculated doses. The two sets of
proton data represent the absorbed dose as calculated by using the cell
mass according to (i) the range of the proton in a cell and (ii) according to
the entire cell thickness of 6 microns. For comparison and RBE
determination, cell survival with 250 kVp x-rays is also plotted. The proton
data are fit to a linear relationship in the semi-logarithmic plot.
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V79 Survival with 390 keV Protons and 250 kVp X-rays
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Figure 3-3: The cell survival curve generated when 390 ± 20 keV protons
irradiate V79 cells to several different calculated doses. For comparison
and RBE determination, cell survival with 250 kVp x-rays is also plotted.
The proton data are fit to a linear relationship in the semi-logarithmic plot.
V79 Survival with 1.2 MeV Protons and 250 kVp X-rays
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Figure 3-4: The cell survival curve generated when 1.2 ± 0.04 MeV protons
irradiate V79 cells to several different calculated doses. For comparison
and RBE determination, cell survival with 250 kVp x-rays is also plotted.
The proton data are fit to a linear relationship in the semi-logarithmic plot
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Figure 3-5: V79 cell survival curves for 94 keV, 250 keV, 390 keV, and 1.2
MeV protons as compared to 250 kVp x-rays. The absorbed doses of the
cell were calculated based on the range of the proton in the cell.
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Figure 3-6: V79 cell survival curves for 94keV, 250 keV, 390 keV, and 1.2
MeV protons as compared to 250 kVp x-rays. For purposes of calculating
the absorbed dose, the entire mass of the cell was used regardless of the
proton range.
3.2 Proton RBEs
The survival curves presented in Section 3.1 were used to obtain proton RBE
values at four levels of survival for the four proton energies. Tables 3-1 through
3-6 present the RBEs and the associated uncertainties for the four proton
energies. Figure 3-6 shows the how the RBEs at the same four levels of survival
vary with proton energy.
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Relative Biological Effectiveness of 94 keV Protons [The cell
mass for purposes of calculating the
range of the proton in the cell.]
absorbed dose to the cell is based on the
Table 3-2: Relative Biological Effectiveness of 94 keV Protons [The cell
mass for purposes of calculating the absorbed dose to the cell is based on the
entire cell thickness of 6 pm.]
Surviving X-ray Dose Proton RBE Uncertainty
Fraction (Gy) Dose (Gy)
0.5 4.2 0.3 14 5.6
0.37 5.3 0.5 11 4.0
0.1 9.3 1.0 9.3 3.4
0.01 13.7 2.1 6.5 2.4
Table 3-3:
mass for pu
range of the
Relative Biological Effectiveness of 250 keV Protons[The cell
rposes of calculating the absorbed dose to the cell is based on the
proton in the cell.]
Table 3-4: Relative Biological Effectiveness of 250 keV Protons[The cell
mass for purposes of calculating the absorbed dose to the cell is based on the
entire cell thickness of 6 m.]
Surviving X-ray Dose Proton RBE Uncertainty
Fraction (Gy) Dose (Gy)
0.5 4.2 0.6 7 2.4
0.37 5.3 0.8 6.6 2.1
0.1 9.3 1.9 4.9 1.6
0.01 13.7 3.9 3.5 1.1
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Surviving X-ray Dose Proton RBE Uncertainty
Fraction (Gy) Dose (Gy)
0.5 4.2 1.0 3.9 1.0
0.37 5.3 1.6 3.4 0.8
0.1 9.3 3.6 2.6 0.6
0.01 13.7 7.2 1.9 0.4
Surviving X-ray Dose Proton RBE Uncertainty
Fraction (Gy) Dose (Gy)
0.5 4.2 0.9 4.6 0.8
0.37 5.3 1.3 4.1 0.5
0.1 9.3 3.0 3.1 0.4
0.01 13.7 6.0 2.3 0.2
Table 3-1:
Table 3-5: Relative Biological Effectiveness of 390 keV Protons
Surviving X-ray Dose Proton RBE Uncertainty
Fraction (Gy) Dose (Gy)
0.5 4.2 0.7 5.8 1.3
0.37 5.3 1.0 5.1 1.1
0.1 9.3 2.4 3.9 0.8
0.01 13.7 4.8 2.9 0.6
Table 3-6: Relative Biological Effectiveness of 1.2 MeV Protons
Surviving X-ray Dose Proton RBE Uncertainty
Fraction (Gy) Dose (Gy)
0.5 4.2 1.2 3.6 0.9
0.37 5.3 1.7 3.2 0.7
0.1 9.3 3.9 2.4 0.5
0.01 13.7 7.8 1.8 0.4
RBE as a Function of Proton Energy for Various Levels
of Survival
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Figure 3-7: RBEs of V79 cells as a function of proton energy for 50, 37, 10,
and 1 percent survival. The cell mass for the purposes of calculating
absorbed are based on the range of the proton in the cell.
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3.3 Uncertainties
The cell survival curves have uncertainties in both the absorbed dose to the
V79 cells and in the cell surviving fraction. As a result, the RBEs have
uncertainties since they are the ratio of the absorbed doses.
3.3.1 Dose Uncertainty
The uncertainty in the absorbed dose is determined by combining the
uncertainties of the individual parameters (as seen in Equation 2-5) that are used
to calculate the dose. Table 3-6 presents a breakdown of the individual
components that affect the uncertainty in the dose. Missing from Table 3-6 is the
mass of the cell. Measurements of the cell size were made by various
researchers using scanning electron microscopy, where they found that cell size
varies by twenty percent [Bird et al. 1980, Goodhead and Thacker 1977, Raju et
al. 1987]. Since the product of the parameters in Table 3-6 is proportional to
dose, the uncertainty in the dose is determined by adding, in quadrature, the
uncertainty in each of the parameters. The cell mass uncertainty is also added,
in quadrature, to the uncertainties of the components of dose in Table 3-1.
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Table 3-7: Components that Contribute to the Uncertainty in the Absorbed
Dose
Dose oc Proton Energy x Beam Current x Irradiation Time
Accelerator Terminal Electrometer Gate Valve Closing
Voltage
Secondary Electron Stop Watch
Energy Straggling Effect
Through Kapton
Energy Straggling
Through Stripping Foil
Energy Straggling
_Through Cell _____ _
Each uncertainty component is described separately in the following sections.
The absorbed dose of the V79 cells from the 250 kVp x-ray machine is
determined by first measuring an actual exposure rate from the machine at the
point of irradiation. This measurement is taken periodically by staff at MGH
where the x-ray machine is located. A comparison of the measurement over
time revealed that the rate varied by as much as five percent. When the
exposure rate is converted into a dose rate by Equation 3-1, the five percent
uncertainty in the exposure rate passes onto the dose rate.
Dose Rate = 34 J / kg pm / Pm x Exposure Rate [3-1]C/kg [a'/Pa
where, the dose rate is in Gy/s and the exposure rate in C/kg per second and
pm/pm and pa/pa are the ratio of photon energy absorption coefficients to the
density for tissue and air, respectively.
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3.3.1.1 Accelerator Terminal Voltage
The initial energy of the proton beam is controlled by setting the terminal
voltage of the accelerator. This voltage, however, is not constant and is subject
to noise fluctuations. Furthermore, the terminal voltage is set by the user and
then generated by the accelerator electronics to match the set-point. A feedback
mechanism exists within which the generated terminal voltage continuously tries
to match the set-point. As a result, the actual terminal voltage will not be
constant and will fluctuate as it tries to match the set-point. For each terminal
setting used to generate the four proton energies used, the variability in the
voltage was measured with the voltmeter in the accelerator's switching converter.
The signal from the switching converter is fed into an x-y plotter that plots the
variability in the voltage over the same amount of time used for the V79 cell
irradiations. For all the energies, the variability in the terminal voltage was
approximately ±312 volts. Since the terminal voltages used for the experiments
were on the order of hundreds of kilovolts, the uncertainties in the proton
energies from the variation in the terminal voltage are generally less than a tenth
of a percent.
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3.3.1.2 Proton Energy Straggling through Stripping Foil
As the proton beam reaches the cell it must pass through various materials
and as result, an uncertainty in the energy due to straggling through these
materials is generated.
As described in Section 2.1.1.1, when the hydrogen ion beam reaches the
accelerator terminal, it must pass through a graphite stripping foil to remove its
two electrons in order to transform it into a proton beam. The stripping foil is
either 5 mg/cm2 (200A) or 10 mg/cm2 (400 A) in thickness. The proton energy
straggling through these foils is calculated (by TRIM 2000) to be no greater than
1.5% over the entire range of proton energies used in these experiments [Ziegler
1998].
3.3.1.3 Proton Energy Straggling through Kapton
The most significant proton energy loss is through the Kapton window, and
thus, the window contributes the greatest amount of energy straggling. The
lower the desired energy to the V79 cells, the more energy straggling through the
Kapton window. The uncertainties in the proton energies due to the Kapton
window are 18.15%, 6.6%, 4.91%, and 2.48% for the 94 keV, 250 keV, 390 keV,
and 1.2 MeV protons, respectively. These uncertainties were determined by
using TRIM which provides the average energy and standard deviation of the
protons after having passed through the Kapton.
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3.3.1.4 Proton Range and Energy Straggling through Cell
The portion of the cell mass used in the calculation of absorbed dose depends
on the range of the proton in the cell. For the 94 and 250 keV protons, which do
not pass through the cell completely, their range and energy straggling, as
determined by TRIM 2000, are taken into account. In order to determine the
uncertainty in the dose, the uncertainty in the cell mass is first calculated based
on the uncertainty in the proton range. Then the uncertainty in the proton energy
is added to the cell mass uncertainty in quadrature because dose is energy per
unit mass. The effect on the absorbed dose is less than eight percent for the two
proton energies.
For the 390 keV and the 1.2 MeV protons which completely pass through the
cell, their energy straggling as calculated by TRIM 2000 are considered. The
energy straggling of the 390 keV protons was calculated to be seven percent
while that for the 1.2 MeV protons was less than one percent.
3.3.1.5 Current on Target Measurement (Electrometer)
The currents that are used in the calculation of dose are measured on an
aluminum plate by an electrometer prior to cell irradiations (see Section 2.6.2).
As a result, there is a inherent uncertainty in the beam current that is actually
irradiating the cells because this current is not measured during the irradiations.
The consistency and repeatability of the proton beam current is checked
throughout the experiments. In general, the current is stable to within ten
percent over the course of an entire irradiation sequence [12-15 Kapton windows
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with cells] at a given energy. When there is a change in the measured beam
current, the current measured before the particular cell window irradiation is
averaged with the current measured following the irradiation, to give the current
that is used in the calculation of dose for that particular cell window.
The electrometer used to measure the proton beam current is also subject to
noise and uncertainty. The beam currents that are measured for these
experiments is on the order of three to five picoamperes. At such low currents,
the electrometer is very susceptible to electronic noise in the circuit wires
connected to the beam target. Over all of the experiments, the electrometer dark
current (current measurement in the absence of beam) was 0.1 pA. With beam
on the target, the current fluctuations ranged from 0.2 pA to 0.5 pA. When the
current fluctuations are considered as a fraction of the measured beam current,
the uncertainties in the beam current ranged from 5% to 15% over all
experiments. When these uncertainties are combined with the uncertainty in the
current as measured by the aluminum plate, the total uncertainty in the current
on target ranges from 11% to 18%.
3.3.1.6 Secondary Electron Effect
The actual proton beam current and the measured one can also differ as a
result of secondary electrons escaping the beam target. These electrons are
created by the ionizations and de-excitations of atoms as the incident proton
beam strikes the aluminum plate. The absence of these electrons will serve to
inflate the measurement of the positively charged, proton beam current due to
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the loss of negative charge from the target. An attempt was not made in these
experiments to quantify this effect over the range of proton energies used.
3.3.1.7 Timing of Irradiation
As mentioned in Section 2.6, the irradiation of the cells is controlled by
manually closing a pneumatic gate valve (with a millisecond closing time) when a
predetermined time has been reached. The coordination of closing the gate
valve at the predetermined time introduces uncertainty in the irradiation time.
From several timing runs it was determined that the average timing uncertainty is
0.5 seconds. The relative uncertainty in the timing thus depends on the
irradiation time to a specific cell window. The shortest irradiations for 2.5
seconds produced the greatest uncertainties of twenty percent. The longest
irradiations resulted in only a three percent timing uncertainty.
3.3.2 Cell Colony (Surviving Fraction) Uncertainty
The uncertainty in the number of cell colonies (or surviving fraction), depends
on several factors. These factors are discussed individually in this section.
3.3.2.1 Counting Error
The uncertainty associated with the actual counting of colonies is determined
by taking the square root of the number colonies counted. For these
experiments, at least 200 colonies were counted, thus creating an uncertainty of
no more than seven percent.
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3.3.2.2 Variability
For each dose point, at least three cell windows were used to determine
surviving fraction. Uncertainty in the surviving fraction for a given dose point is
then introduced by averaging the number of surviving colonies and determining
the standard deviation. This uncertainty usually amounted to less than ten
percent.
3.3.3 Uncertainties in RBE
In order to determine the uncertainties in the RBEs, the proton survival curve
data are fit to linear relationships on semi-logarithmic graphs. A linear
relationship is chosen because a shoulder region indicative of cellular repair is
not present for high LET radiation such as low energy protons. As mentioned in
Section 1.4.2, low energy protons tend to create double strand breaks in DNA to
inactivate cells which is an error prone repair process more likely to result in cell
death. A 95% confidence interval is determined for the slope of the fitted lines.
Then, for each level of survival, the uncertainty in the RBE is determined based
on the confidence interval by adding, in quadrature, the uncertainties in the
proton and the 250 kVp x-ray doses.
The cell survival curves and proton RBEs presented for the four proton
energies in this chapter are interpreted and compared with estimates presented
in the literature in Chapter 4.
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4 Discussion and Future Work
The proton RBEs generated in this thesis can be of use to BNCT by
incorporating them into treatment planning software. In one type of software, a
common method of determining the absorbed dose to tissue is to track individual
neutron energy deposition events via a Monte Carlo code. The average neutron
energy in prescribed tissue volumes (masses) is determined by the code, and as
result, so are the absorbed doses. Proton RBEs can then be incorporated into
the analysis by linking average neutron energies to proton recoil spectra with
known RBEs. The software can then develop dose volume histograms in the
same set of photon equivalent dose units. This allows physicians to make more
informed decisions as to the appropriate beams and doses to use for treating a
particular tumor.
4.1 Effect of Specifying Cell Mass
For these experiments, the single most important quantity in determining the
RBEs was the calculation of absorbed dose to the cells. As demonstrated in
Section 2.5, these doses were calculated based on a set of assumptions. The
most critical of these assumptions was the mass into which the proton deposits
its energy. For the 390 keV and the 1.2 MeV protons, their ranges are great
enough so that they pass through the cell completely. Thus, the cell mass is
calculated based on the average cell thickness of 6 ptm [Belli et al. 1998]. The 94
keV and 250 keV protons do not pass completely through the entire cell and as a
result, the masses into which they deposit their energy can be determined
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differently. Furthermore, the Bragg peaks of the 94 keV and 250 keV protons
occur at 1.56 pm and 3.78 pm, respectively [Ziegler 1998, TRIM 2000]. Thus,
the largest concentration of dose is absorbed by the cell at these locations since
the ranges of these two protons are only 1.61 tm and 3.82 gim, respectively.
Chapter 3 presented the proton irradiation cell survival curves using two different
ways of determining the cell thickness. The first way used the cell thickness that
corresponded to the range of the proton in the cell while the second way used
the entire cell thickness of 6pm. These two ways of determining the cell mass
were used because it is not clear what mass to use in the determination of
absorbed dose. The quantity, absorbed dose, is defined as the limit of the mean
specific energy, z, as the mass, m, tends to zero [Greening 1985]. The specific
energy is defined as the energy imparted by ionizing radiation divided by the
mass into which the energy is imparted [Greening 1985]. Absorbed dose is
treated like a point function and has a value at every point in an irradiated object.
In determining absorbed dose, it is really the specific energy that is measured.
In most cases z is large enough and the individual energy deposition events
numerous enough that the uncertainties in the measurements are negligible.
However, when the mass is very small (as for the V79 cells), the strict definition
of absorbed dose begins to fail. On the microscopic scale, defining what the
"mass" is greatly affects the dose. In the case of some of the experiments
described here, the energy is deposited over a range that does not include the
entire cell, however, the overall effect of these protons to the entire cell is what is
measured when cell survival is assessed. Thus, on one hand it may make sense
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to consider the entire cell mass. However, if the proton does not pass into a
certain amount of mass, then no energy is deposited in that mass and hence no
absorbed dose.
When the entire cell mass is used in the calculation of dose, the relative
positions of cell survival curves to one another change from what is observed
when dose is calculated using only that mass corresponding to the range of the
proton. The calculated doses for the 94 keV protons decrease by seventy
percent due to the large increase in the assumed cell mass. The cell mass
increase for the 250 keV protons results in absorbed doses thirty-six percent less
than when the cell mass is calculated based on the range.
Shifting the doses lower for these two energies shifts the cell survival curves
relative to one another. When the cell mass is calculated based on the range,
the most biologically effective protons are the 390 keV protons, followed by the
250 keV ones, then those of 94 keV, and finally the 1.2 MeV protons. These
results are somewhat expected and explainable based on the ranges and LETs
of the protons. The 94 keV protons do not completely pass through the cell and
in all probability do not even reach the cell nucleus, on average. Thus, they are
not as biologically effective as the 250 keV and the 390 keV protons. The 250
keV protons have a range that is about half the thickness of the cell. As result,
these protons probably reach the nucleus on average. The 390 keV protons
have a range that is about half a micron longer than the cell thickness. Thus,
they always pass through the cell nucleus. The 1.2 MeV protons easily traverse
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the entire cell thickness. The relative biological effectiveness of the 1.2 MeV and
94 keV protons are the same, within uncertainty.
Using the entire cell mass for all four proton energies shifted the cell survival
curves such that the most effective proton energy is 94 keV, followed by the rest
of the energies in increasing order. Shifting the 94 keV cell survival curve below
the rest of the curves, increased the 94 keV proton RBEs by approximately a
factor of two. The trend of increasing biological effectiveness with decreasing
proton energy, would be more expected if the protons were created in the cells
as opposed to a beam being directed at them. The 94 keV and 250 keV
protons, with their higher LETs, would then be created throughout the cell where
they would have the greatest chance of interacting with the cell nucleus to
inactivate the cell.
4.2 Uncertainty Effects in Data Interpretation
Even though the uncertainties in the RBEs are large, differences in the RBEs
as a function of energy can be detected, even when uncertainty is taken into
account. At all levels of survival, the 390 keV proton RBEs are different from
those due to the 94 keV and 1.2 MeV protons. However, the 390 keV and 250
keV protons are within uncertainty of one another. In addition, the 94 keV and
1.2 MeV protons are within uncertainty. When the mass of the entire cell is used
in the RBE calculation, the 94 keV protons are different from the other three
energies, at all levels of survival.
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4.3 Comparisons to Other Work
Presented in this thesis, thus far, are only the RBEs for protons at various
energies. However, comparisons will be made to both the biological
effectiveness of protons and monoenergetic neutrons, as found in the literature.
While all of the conditions, such as proton energy, end point, and reference
radiation will not match exactly, a suitable comparison is still possible.
In Figure 3-7, there is an apparent energy trend in the RBEs, where RBE rises
to a maximum at 390 keV. The energy gap between 390 keV and 1.2 MeV is
large, and the RBE may in fact continue to rise before falling at 1.2 MeV. Work
by Hall et al. and Geard, using monoenergetic neutrons, demonstrated that there
is a peak in neutron biological effectiveness around 350 keV (see Figure 1-1 for
Hall et al. results) [Hall et al. 1975, Geard 1996]. Hall et al. used neutrons of
various energies created from the p-T and d-T reactions to evaluate cell survival
in V79 cells at four different end points using 250 kVp x-rays as a reference
radiation [Hall et al. 1975]. Geard, on the other hand, looked at chromosomal
aberrations in Vicia faba cells due to irradiation by neutrons from the p-T reaction
[Geard 1996]. The lowest neutron energies used in these two studies were 110
keV by Hall et al. and 230 keV by Geard. The Blue et al. calculation of neutron
RBEs also demonstrated that 350 keV is the most biologically effective neutron
energy [Blue et al. 1993].
The available proton RBE data are from Folkard et al., Bettega et al., Perris et
al., and Belli et al. [Perris et al. 1986, Folkard et al. 1996, Bettega et al. 1998,
Belli et al. 1998]. The RBE of 1.91 ± 0.30 for V79 cells at 10% survival for 1.07
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MeV protons, as reported by Folkard et al., is within error of the 2.4 ± 0.8 RBE
determined for 1.2 MeV protons in this thesis (based on using the entire cell
mass in the determination of dose). However, the 1.07 MeV proton RBE is
expected to be greater than that for 1.2 MeV protons, due to the lower energy
protons having a higher LET. The 1.07 MeV protons RBE should be scaled
slightly higher to take into account the fact that the reference radiation was 240
kVp x-rays as opposed to 250 kVp for this thesis.
Belli et al. and Perris et al. also developed RBEs at 10% survival for V79 cells.
At their lowest energies of 3.0 MeV an RBE of 1.8 (no uncertainty provided) was
reported with 250 kVp x-rays as the reference for Belli et al. and an RBE of 1.95
± 0.20 for Perris et al. with Co-60 as the reference radiation [Belli et al. 1998,
Perris et al. 1986]. The Perris et al. RBE is slightly lower by ten to fifteen percent
when 250 kVp x-rays are used which is consistent with the greater biological
effectiveness of these x-rays. Consistent with a lower LET, the RBE of 2.4 ± 0.2
for the 1.2 MeV protons presented in this thesis is higher than those RBEs
reported for 3.0 MeV by Belli et al. and Perris et al [Belli et al. 1998, Perris et al.
1986].
A final comparison to other work can be made by comparing the 2.9 ± 0.7
RBE at ten percent survival following irradiation by 0.72 MeV protons generated
by Bettega et al [Bettega et al 1998]. Interpolating the RBEs at proton energies
of 1.2 MeV and 390 keV from this thesis, gives an RBE of 3.2 ± 0.5 at 0.72 MeV.
This interpolated value is within uncertainty of the Bettega et al. reported RBE.
However, Co-60 was used as the reference radiation and survival of C3H1OT1/2
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cells as the end-point. The use of Co-60 lowers the Bettega RBE by about ten
percent. A comparison of the cell survival curves for the two cell lines indicates
that the difference in cell line is negligible when applied to RBE.
In general the RBE values presented in this thesis are consistent with values
reported by other researchers.
4.4 Sample Neutron RBE Determination
The stated goal of this thesis work was to experimentally determine the RBEs
of fast neutrons over the energy range of interest for BNCT. The approach was
to simulate the recoil protons created when fast neutrons slow down and
determine RBEs by integrating the proton RBEs expected over the proton recoil
spectrum of a given neutron energy. In order to effectively integrate the proton
RBEs, proton RBEs at various energies are needed in order to adequately
discretize the continuous proton recoil spectrum. In this work, RBEs for only four
proton energies were determined. However, a very crude estimate of the RBE
for 1.2 MeV neutrons is determined to provide an example as to the process of
determining RBE for a monoenergetic neutron beam.
The continuous proton recoil energy spectrum must be separated into energy
bins. The bins are generated by selecting the mid-point energy between two
proton energies with known RBEs. Then the RBE for the entire energy bin is
assumed to be the same as the RBE for the proton energy that is within that bin.
Thus, in this example, there are four bins and the RBEs correspond to those for
the 94 keV, 250 keV, 390 keV, and 1.2 MeV protons. Figure 4-1 shows the bins
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that were selected for this example. The energy bins are as follows: bin 1 is 0 -
172 keV, bin 2 is 172 - 320 keV, bin 3 is 320 - 790 keV, and bin 4 is 790 keV -
1.2 MeV. The fractional area of each energy bin to the total area is calculated to
give the fraction of recoil protons in that specific energy bin. Finally, the
weighted average of the RBEs for the energy bins is calculated to give the RBE
of the monoenergetic neutron beam. For 1.2 MeV neutrons, the RBE is
calculated to be 3.0 ± 0.9 at ten percent survival. Increasing the number of
energy bins will greatly increase the accuracy of the neutron RBE.
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Figure 4-1: The proton recoil energy spectrum expected when 1.2 MeV
monoenergetic neutrons slow down in tissue. The energy bins selected for
RBE analysis are : 0 - 172 keV, 172 - 320 keV, 320 - 790 keV, and 790 -
1200 keV
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4.5 Recommendations for Future Work
The large uncertainties in the RBEs are mainly due to the uncertainty in the
calculated absorbed doses to the cells. Reduction of the dose uncertainty can
be achieved by using thinner vacuum windows to greatly reduce the energy
straggling of the protons. As mentioned previously, 3 micron polyimides exist
which would greatly reduce straggling and would allow for lower proton energies
(down to about 30 keV) to be investigated. Reducing the uncertainty in the dose
can also be achieved by improving the proton beam current measuring system.
The method used for these experiments does not allow for current monitoring
during cell irradiation. Thus, there is an inherent uncertainty associated with
knowing the proton beam fluence that irradiated the cells.
In order to develop better monoenergetic neutron RBEs, several more proton
energies should be investigated in order to create narrower energy bins. If this
method of neutron RBE determination proves reliable for V79 cells, then
applying it to other cell lines, namely human cell lines would be the next logical
step.
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Appendix: Cell Biology Equipment
A.1 Biological Safety Cabinet
The most significant barrier to cell contamination is the biological safety
cabinet (flow hood) that is used throughout the preparation and handling of the
cells, both prior to and after irradiation.
A.1.1 General Description (of flowhood)
The flow hood selected for the experiments is The Baker Company's
SterilGARD 11-400 Type A (SGII-400). It is situated in a relatively clean area in a
room in the basement of building NW-13 on the MIT campus (see Section 2.1.2).
The placement of the hood was selected so as to minimize its exposure to drafts
and exceptionally dirty air [Jackvony 1998]. The hood weighs approximately 630
lbs. and measures 33.5" deep by 53.5" wide by 88" tall with the work area
measuring 46" in width by 24 5/32" deep by 29 3/8" from the floor. Telescoping
legs on the unit allow the work surface height from the floor to be adjusted from
29 3/8 inches to about 21 inches. A picture of the SGIl-400 can be found in
Figure 2-3. The flow hood serves two purposes: 1. to protect the material (i.e.
the cells) in the flow hood from the external air [prevent contamination]; and 2. to
protect the external environment (i.e. the operator) from the material inside the
flow hood. Since their are no human health risks involved with handing of V79
cells, the more important function of the flow hood is protecting the V79 cells
from contamination.
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A.1.2 Flow Hood Operation [Baker 1995]
The flow hood operation begins by in-taking room air through a series of
strategically placed vents at the vertical plane that separates the non-sterile,
external region, from the sterile region inside the hood. This air is then forced by
a motor/blower through a rear airflow duct to two high efficiency particulate air
(HEPA) filters, which are 99.9999% efficient on all particles of 0.3 microns and
larger. These filters are located above the work surface. Thirty percent of the air
is exhausted through one of the HEPA filters and back into the room. The
remaining seventy percent of the air is circulated through the supply HEPA filter
back onto the work surface. The HEPA-filtered air descends through the work
zone in a vertical laminar flow as "clean" air. At the center of the work surface,
the air splits with a portion of the air exiting to the base of the cabinet via the
front vents and the remainder exits to the base through the rear vents. The most
sterile area of the hood is in its center, therefore, most of the work inside the
hood is conducted in that area [Jackvony 1998].
The materials that the cells will be exposed to are also handled, as much as
possible, within the flow hood. A glass sash, open seven inches, allows for only
hands and forearms to enter the sterile region. In order to minimize the insertion
of foreign material that may potentially contaminate the cells, the hands are
covered with ethyl alcohol cleansed gloves and a clean cotton laboratory coat is
used to cover the forearms. Throughout experiments, the gloves are cleaned
with alcohol, periodically, to ensure sterility. Obviously contaminated gloves are
discarded and replaced.
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A.1.3 Flow Hood Cleaning and Maintenance
Maintaining and cleaning the flow hood is a relatively simple task, yet very
important. Prior to and following each use, it is thoroughly cleaned with 200
proof ethyl alcohol. In the case of dried medium or other spills, warm soap and
water are used followed by ethyl alcohol cleaning to maintain sterility. Further
sterilization methods are performed approximately once a month through the use
of the hood's built-in ultraviolet light. The HEPA filters that remove particulates
from the air are checked for viability annually along with proper operation of the
hood's air flow, by an independent testing laboratory.
A.2 Incubator
An ex-vivo environment similar to that found in-vivo must be simulated in order
for experimental cell lines to divide and form colonies. For these experiments,
the V79 cell line described in Section 2.3.1 is mammalian and requires
mammalian conditions in order to thrive. In particular, a stable growth
environment needs to be maintained at 98.6 OF (37 0C), relatively humid, contain
5% CO2 and be free from external contamination. An incubator satisfies these
conditions and is used to approximate the in-vivo environment.
A.2.1 General Description and Operation [Forma 1998]
The LABA biology laboratory utilizes the Forma Scientific Model 3110 water
jacketed incubator per the advice of the MGH biology laboratory. The geometry
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of the incubator is relatively simple. The incubator is cubic in shape with
dimensions 26.1" wide by 39.5" tall by 25.0" deep and weighs 330 pounds. The
interior is lined with electropolished stainless steel and contains self-supporting
shelves of the same material. A stainless steel humidity pan is situated below
the shelves. The interior of the unit can be viewed through the heated, dual
pane inner glass door that separates the incubation chamber from the exterior
door. The incubator can be seen in Figures 2-3 and 2-4.
The incubator is controlled by a microprocessor that has a user interface
located on the front of the unit. This panel allows the user to input the desired
settings such as temperature and percent CO 2. In addition, it allows for
calibration of the unit and the ability to program temperature and CO 2 level
alarms.
An extremely important characteristic of the incubator is its ability to maintain
the user specified environment. The temperature is maintained through the use
of a water jacket around the incubation chamber. Approximately twelve gallons
of distilled water fill the region between the incubation chamber and the
fiberglass insulation that surrounds the entire unit. The water jacket does not
extend to the exterior door, however the fiberglass does. The glass interior door
previously described provides the necessary insulation at the door. The
insulating layers of the incubator allow the incubation chamber temperature to be
maintained to within 0.2 *C.
Medical grade C02 (99.7% pure) is injected into the unit at a pressure of 12
psi where the unit regulates the C02 concentration to five percent. The air inside
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the chamber is circulated from bottom to top where a HEPA filter cleans the
entire chamber volume of air every minute. The use of two doors and rubber
gaskets serves to seal the chamber and prevents the leakage of CO 2 . The
environmental conditions of the incubator change when the doors are opened.
In general, the doors should be opened as little as possible and should never
stay open for extended periods of time (no longer than thirty seconds). The
incubator quickly returns the chamber to the desired set points once the door is
closed.
A.2.2 Maintenance and Sterility Control
Maintaining a sterile and operational incubator is also relatively easy and
virtually maintenance free. The air inside the incubator is kept free of
particulates through the use of a 99.99% HEPA filter. The entire chamber
volume is filtered every minute. The filter is checked annually and changed as
needed. The sterile, deionized water that is used in the humidity pan is
exchanged on a monthly basis. The actual pan itself is cleaned with 200 proof
ethyl alcohol during the water exchange. The stainless steel shelves are
cleaned with 200 proof ethyl alcohol after each experiment.
When contaminated tissue culture dishes or flasks are identified in the
incubator, they are immediately removed and sealed. The contaminated vessel
is then discarded in a room other than the biology laboratory. This procedure is
followed so as not to introduce the spores from the contamination into the
biology laboratory or the incubator itself [Held 1998]. Once an incubator is
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contaminated, it is very difficult to completely remove the contaminating spores
because just like V79 cells, they thrive in that environment.
A.3 Pipets and Bottles
Individually wrapped, sterile pipets in various sizes are used in all fluid
manipulations associated with the experiments. Each pipet is used only once
and then discarded. Every attempt is made to limit the exposure of the exposed
pipet, especially the pipet tip, to only its desired fluid (i.e. medium, trypsin, etc.).
Those pipets that are accidentally touched by the hand, dropped, or touch any
other object are immediately discarded and a new sterile pipet is obtained and
used. The Pipetmen tips and the Pasteur pipets that are not individually
wrapped are stored inside the flow hood in between experiments.
In any biology laboratory there are usually multiple cell lines being utilized at
any one time by multiple users. Many of the same cell lines utilize the same type
of growth medium as described in section 2.4.2.1. In order to avoid the potential
for cross contamination of cell lines, separate bottles of medium and trypsin are
used for each cell line. To further eliminate inadvertent contamination, each
researcher prepares and uses his own bottles of medium and trypsin. When
using sterile bottles of fluid, they are kept in the sterile environment of the flow
hood as much as possible. In addition, they are only opened while the
necessary amount of fluid is being extracted.
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